Oral Products Containing a Combination of Active Ingredients - Patent application

The formulation of smokeless tobacco products with a blend of active ingredients and sugar alcohols in chewable or meltable forms addresses the lack of diversity in traditional products, providing a satisfying nicotine-free and tobacco-free alternative with enhanced sensory and nutritional benefits.

JP7583809B2Active Publication Date: 2024-11-14NICOVENTURES TRADING LTD

Patent Information

Application Number
JP2022534710
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2020-06-08
Filing Date
2020-12-04
Publication Date
2024-11-14
Estimated Expiration
2040-12-04

AI Technical Summary

Technical Problem

Existing smokeless tobacco products lack diversity in formulation and sensory attributes, failing to provide a satisfying alternative to traditional tobacco use.

Method used

Compositions comprising a combination of active ingredients such as caffeine, taurine, GABA, theanine, tryptophan, vitamins B6 and B12, vitamin C, lemon balm extract, ginseng, citicoline, and sunflower lecithin, along with sugar alcohols and gelling agents, are formulated in chewable or meltable forms to enhance sensory experience and nutritional benefits.

Benefits of technology

The compositions offer a nicotine-free and tobacco-free alternative that enhances user satisfaction with improved taste, texture, and potential health benefits, catering to diverse consumer preferences.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007583809000001
    Figure 0007583809000001
  • Figure 0007583809000002
    Figure 0007583809000002
  • Figure 0007583809000003
    Figure 0007583809000003
Patent Text Reader

Abstract

A composition for oral use is provided, comprising at least one active ingredient selected from caffeine, taurine, GABA, theanine, tryptophan, vitamin B6, vitamin B12, vitamin C, lemon balm extract, carrot, citicoline, sunflower lecithin, or a combination thereof. The composition contains one or more fillers, including a sugar alcohol, and optionally a lipid or binder. The composition may be in a chewable, tablet, or meltable form.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present disclosure relates to compositions intended for human use. The compositions are configured for use in the oral cavity and deliver substances such as flavors and / or active ingredients during use. Such products may include tobacco or tobacco-derived products or may be tobacco-free alternatives. [Background technology]

[0002] Tobacco can be enjoyed in so-called "smokeless" forms. Particularly popular smokeless tobacco products are utilized by placing some form of processed tobacco or tobacco-containing preparation in the user's mouth. Traditional formats for such smokeless tobacco products include moist snuff, snus and chewing tobacco, where smokeless tobacco products are typically formed almost entirely from granulated, granulated or shredded tobacco, and where the smokeless tobacco products are either dispensed by the user or given to the user in individual portions, such as disposable pouches or sachets. Other traditional forms of smokeless products include compressed or agglomerated forms, such as plugs, tablets or pellets. Alternative product formats are also known, such as tobacco-containing gums and mixtures of tobacco with other plant materials.See, for example, U.S. Pat. No. 1,376,586 to Schwartz; U.S. Pat. No. 4,513,756 to Pittman et al.; U.S. Pat. No. 4,528,993 to Sensabaugh, Jr. et al.; U.S. Pat. No. 4,624,269 to Story et al.; U.S. Pat. No. 4,991,599 to Tibbetts; U.S. Pat. No. 4,987,907 to Townsend; U.S. Pat. No. 5,092,352 to Sprinkle, III et al.; U.S. Pat. No. 5,092,352 to White et al. No. 5,387,416 to Williams; U.S. Pat. No. 6,668,839 to Williams; U.S. Pat. No. 6,834,654 to Williams; U.S. Pat. No. 6,953,040 to Atchley et al.; U.S. Pat. No. 7,032,601 to Atchley et al.; and U.S. Pat. No. 7,694,686 to Atchley et al.; U.S. Patent Publication No. 2004 / 0020503 to Williams; U.S. Patent Publication No. 2005 / 01 to Quinter et al. No. 15580; U.S. Patent Publication No. 2006 / 0191548 to Strickland et al.; U.S. Patent Publication No. 2007 / 0062549 to Holton, Jr. et al.; U.S. Patent Publication No. 2007 / 0186941 to Holton, Jr. et al.; U.S. Patent Publication No. 2007 / 0186942 to Strickland et al.; U.S. Patent Publication No. 2008 / 0029110 to Dube et al.; U.S. Patent Publication No. 2008 / 0029116 to Robinson et al. No. 2008 / 0173317 to Robinson et al.; U.S. Patent Publication No. 2008 / 0209586 to Neilsen et al.; U.S. Patent Publication No. 2009 / 0065013 to Essen et al.; and U.S. Patent Publication No. 2010 / 0282267 to Atchley, and WO 2004 / 095959 to Arnarp et al., each of which is incorporated herein by reference, for the types, ingredients and processing methods of smokeless tobacco formulations.

[0003] The construction of smokeless tobacco products that combine tobacco materials with various binders and fillers has been proposed more recently, with exemplary product formats including lozenges, pastilles, gels, extruded forms, and the like. See, for example, U.S. Patent Application Publication No. 2008 / 0196730 to Engstrom et al.; U.S. Patent Application Publication No. 2008 / 0305216 to Crawford et al.; U.S. Patent Application Publication No. 2009 / 0293889 to Kumar et al.; U.S. Patent Application Publication No. 2010 / 0291245 to Gao et al.; U.S. Patent Application Publication No. 2011 / 0139164 to Mua et al.; U.S. Patent Application Publication No. 2012 / 0037175 to Cantrell et al.; U.S. Patent Application Publication No. 2012 / 0055494 to Hunt et al.; U.S. Patent Application Publication No. 2012 / 0138073 to Cantrell et al.; U.S. Patent Application Publication No. 2012 / 013 No. 8074; U.S. Patent Application Publication No. 2013 / 0074855 to Holton, Jr.; U.S. Patent Application Publication No. 2013 / 0074856 to Holton, Jr.; U.S. Patent Application Publication No. 2013 / 0152953 to Mua et al.; U.S. Patent Application Publication No. 2013 / 0274296 to Jackson et al.; U.S. Patent Application Publication No. 2015 / 0068545 to Moldoveanu et al.; U.S. Patent Application Publication No. 2015 / 0101627 to Marshall et al.; and U.S. Patent Application Publication No. 2015 / 0230515 to Lampe et al., each of which is incorporated herein by reference. [Prior art documents] [Patent documents]

[0004] [Patent Document 1] U.S. Pat. No. 1,376,586 [Patent Document 2] U.S. Pat. No. 4,513,756 [Patent Document 3] U.S. Pat. No. 4,528,993 [Patent Document 4] U.S. Pat. No. 4,624,269 [Patent Document 5] U.S. Pat. No. 4,991,599 [Patent Document 6] U.S. Pat. No. 4,987,907 [Patent Document 7] U.S. Patent No. 5,092,352 [Patent Document 8] U.S. Pat. No. 5,387,416 [Patent Document 9] U.S. Patent No. 6,668,839 [Patent Document 10] U.S. Patent No. 6,834,654 [Patent Document 11] U.S. Patent No. 6,953,040 [Patent Document 12] U.S. Patent No. 7,032,601 [Patent Document 13] U.S. Patent No. 7,694,686 [Patent Document 14] US Patent Application Publication No. 2004 / 0020503 [Patent Document 15] US Patent Application Publication No. 2005 / 0115580 [Patent Document 16] US Patent Application Publication No. 2006 / 0191548 [Patent Document 17] US Patent Application Publication No. 2007 / 0062549 [Patent Document 18] US Patent Application Publication No. 2007 / 0186941 [Patent Document 19] US Patent Application Publication No. 2007 / 0186942 [Patent Document 20] US Patent Application Publication No. 2008 / 0029110 [Patent Document 21] US Patent Application Publication No. 2008 / 0029116 [Patent Document 22] US Patent Application Publication No. 2008 / 0173317 [Patent Document 23] US Patent Application Publication No. 2008 / 0209586 [Patent Document 24] US Patent Application Publication No. 2009 / 0065013 [Patent Document 25] US Patent Application Publication No. 2010 / 0282267 [Patent Document 26] International Publication No. 2004 / 095959 [Patent Document 27] US Patent Application Publication No. 2008 / 0196730 [Patent Document 28] US Patent Application Publication No. 2008 / 0305216 [Patent Document 29] US Patent Application Publication No. 2009 / 0293889 [Patent Document 30] US Patent Application Publication No. 2010 / 0291245 [Patent Document 31] US Patent Application Publication No. 2011 / 0139164 [Patent Document 32] US Patent Application Publication No. 2012 / 0037175 [Patent Document 33] US Patent Application Publication No. 2012 / 0055494 [Patent Document 34] US Patent Application Publication No. 2012 / 0138073 [Patent Document 35] US Patent Application Publication No. 2012 / 0138074 [Patent Document 36] US Patent Application Publication No. 2013 / 0074855 [Patent Document 37] US Patent Application Publication No. 2013 / 0074856 [Patent Document 38] US Patent Application Publication No. 2013 / 0152953 [Patent Document 39] US Patent Application Publication No. 2013 / 0274296 [Patent Document 40] US Patent Application Publication No. 2015 / 0068545 [Patent Document 41] US Patent Application Publication No. 2015 / 0101627 [Patent Document 42] US Patent Application Publication No. 2015 / 0230515 Summary of the Invention [Means for solving the problem]

[0005] (Brief summary) The present disclosure generally provides compositions adapted for use in the oral cavity, the compositions comprising at least one active ingredient and one or more fillers. The compositions may be in chewable, tablet or meltable form.

[0006] In one aspect, the disclosure provides a composition in a chewable form adapted for use in the oral cavity, the composition comprising at least one active ingredient selected from the group consisting of caffeine, taurine, GABA, theanine, tryptophan, vitamin B6, vitamin B12 (or other B vitamins), vitamin C, lemon balm extract, carrot, citicoline, sunflower lecithin, and combinations thereof; one or more sugar alcohols in an amount of at least 50% by weight based on the total weight of the composition; pectin; and an organic acid, a gelling agent, or both, wherein the composition is a homogenous mixture.

[0007] In one embodiment, the one or more sugar alcohols are a combination of isomalt and maltitol. In one embodiment, the composition comprises isomalt in an amount of about 10 to about 25% by weight, based on the total weight of the composition; maltitol in an amount of about 50 to about 75% by weight, based on the total weight of the composition; and pectin in an amount of about 1 to about 3% by weight, based on the total weight of the composition.

[0008] In one embodiment, the organic acid is citric acid. In one embodiment, the gelling agent is a calcium salt. In one embodiment, the calcium salt is calcium diphosphate.

[0009] In one embodiment, the at least one active ingredient comprises caffeine.

[0010] In one embodiment, the at least one active ingredient includes theanine.

[0011] In one embodiment, the at least one active ingredient includes taurine.

[0012] In one embodiment, the at least one active ingredient includes GABA.

[0013] In one embodiment, the at least one active ingredient comprises tryptophan.

[0014] In one embodiment, the at least one active ingredient includes vitamin B6, vitamin B12, or both, for example, about 0.008% to about 0.07% total by weight of vitamins B6 and B12.

[0015] In one embodiment, the at least one active ingredient comprises Vitamin C.

[0016] In one embodiment, the at least one active ingredient includes ginseng.

[0017] In one embodiment, the at least one active ingredient comprises lemon balm extract.

[0018] In one embodiment, the at least one active ingredient comprises a combination of caffeine, theanine, and optionally ginseng. In one embodiment, caffeine is present in an amount of about 1 to about 4% by weight based on the total weight of the composition; theanine is present in an amount of about 1 to about 4% by weight based on the total weight of the composition; and ginseng, if present, is present in an amount of about 0.1 to about 0.6% by weight based on the total weight of the composition. In one embodiment, the composition further comprises citicoline or sunflower lecithin.

[0019] In one embodiment, the at least one active ingredient comprises a combination of theanine, gamma aminobutyric acid (GABA), and optionally lemon balm extract. In one embodiment, theanine is present in an amount of about 1 to about 3% by weight, based on the total weight of the composition; GABA is present in an amount of about 1.5 to about 4% by weight, based on the total weight of the composition; and lemon balm extract, if present, is in an amount of about 0.25 to about 2% by weight, based on the total weight of the composition.

[0020] In one embodiment, the at least one active ingredient comprises a combination of caffeine, taurine, and vitamin C. In one embodiment, caffeine is present in an amount of about 1 to about 4% by weight, based on the total weight of the composition; taurine is present in an amount of about 1 to about 4% by weight, based on the total weight of the composition; and vitamin C is present in an amount of about 1 to about 3% by weight, based on the total weight of the composition. In one embodiment, the composition further comprises trisodium citrate. In one embodiment, the composition further comprises vitamin B6, vitamin B12, or both. In one embodiment, the at least one active ingredient comprises a combination of caffeine, taurine, and vitamin B6, vitamin B12, or both.

[0021] In one embodiment, the composition further comprises at least one additional ingredient selected from water, sweeteners, salts, flavors, buffers, emulsifiers, colorants, processing aids, and combinations thereof.

[0022] In one embodiment, the composition further comprises magnesium, for example, in an amount of about 0.1% to about 2% by weight or about 0.2 to about 1% by weight based on elemental magnesium. In one embodiment, the magnesium is in the form of a magnesium salt. In one embodiment, the magnesium salt is magnesium gluconate.

[0023] In one embodiment, the composition is nicotine-free.

[0024] In one embodiment, the composition is tobacco-free.

[0025] In another aspect, provided is a composition in the form of a tablet adapted for use in the oral cavity, comprising at least one active ingredient selected from the group consisting of caffeine, taurine, GABA, theanine, tryptophan, vitamin B6, vitamin B12 (or other B vitamins), vitamin C, lemon balm extract, carrot, citicoline, sunflower lecithin, and combinations thereof; a glucose-polysaccharide blend; and a sugar alcohol, wherein the tablet form contains the composition as a homogenous mixture.

[0026] In one embodiment, the glucose-polysaccharide blend is present in an amount of about 35 to about 55% by weight, based on the total weight of the composition; the sugar alcohol is present in an amount of about 30 to about 45% by weight, based on the total weight of the composition. In one embodiment, the sugar alcohol is isomalt, erythritol, sorbitol, arabitol, ribitol, maltitol, dulcitol, iditol, mannitol, xylitol, lactitol, or combinations thereof. In one embodiment, the sugar alcohol is isomalt.

[0027] In one embodiment, the at least one active ingredient comprises caffeine.

[0028] In one embodiment, the at least one active ingredient includes theanine.

[0029] In one embodiment, the at least one active ingredient includes taurine.

[0030] In one embodiment, the at least one active ingredient comprises tryptophan.

[0031] In one embodiment, the at least one active ingredient includes GABA.

[0032] In one embodiment, the at least one active ingredient includes vitamin B6, vitamin B12, or both, for example, about 0.008% to about 0.07% total by weight of vitamins B6 and B12.

[0033] In one embodiment, the at least one active ingredient comprises Vitamin C.

[0034] In one embodiment, the at least one active ingredient includes ginseng.

[0035] In one embodiment, the at least one active ingredient comprises lemon balm extract.

[0036] In one embodiment, the at least one active ingredient comprises a combination of caffeine, theanine, and optionally ginseng. In one embodiment, caffeine is present in an amount of about 3 to about 5% by weight based on the total weight of the composition; theanine is present in an amount of about 3 to about 5% by weight based on the total weight of the composition; and ginseng, if present, is present in an amount of about 0.4 to about 0.6% by weight based on the total weight of the composition. In one embodiment, the composition further comprises citicoline or sunflower lecithin.

[0037] In one embodiment, the at least one active ingredient comprises a combination of caffeine and vitamin B6, vitamin B12, or both. In one embodiment, the at least one active ingredient comprises a combination of caffeine and taurine. In one embodiment, the at least one active ingredient comprises a combination of caffeine, taurine, and vitamin B6, vitamin B12, or both.

[0038] In one embodiment, the at least one active ingredient comprises a combination of theanine, gamma aminobutyric acid (GABA), and optionally lemon balm extract. In one embodiment, theanine is present in an amount of about 3 to about 5% by weight, based on the total weight of the composition; GABA is present in an amount of about 4 to about 6% by weight, based on the total weight of the composition; and lemon balm extract, if present, is in an amount of about 3 to about 4% by weight, based on the total weight of the composition.

[0039] In one embodiment, the at least one active ingredient comprises theanine and tryptophan. In one embodiment, the at least one active ingredient comprises theanine and vitamin B6, vitamin B12, or a combination thereof. In one embodiment, the at least one active ingredient comprises theanine, tryptophan, and vitamin B6, B12, or a combination thereof.

[0040] In one embodiment, the at least one active ingredient comprises caffeine and taurine. In one embodiment, the at least one active ingredient comprises a combination of caffeine, taurine and vitamin C. In one embodiment, the caffeine is present in an amount of about 3 to about 5% by weight, based on the total weight of the composition; the taurine is present in an amount of about 4 to about 6% by weight, based on the total weight of the composition; and the vitamin C is present in an amount of about 4 to about 6% by weight, based on the total weight of the composition. In one embodiment, the composition further comprises trisodium citrate.

[0041] In one embodiment, the composition further comprises at least one additional ingredient selected from sweeteners, salts, flavorings, buffers, emulsifiers, colorants, processing aids, and combinations thereof.

[0042] In one embodiment, the composition further comprises magnesium, for example, in an amount of about 0.1% to about 2% by weight or about 0.2 to about 1% by weight based on elemental magnesium. In one embodiment, the magnesium is in the form of a magnesium salt. In one embodiment, the magnesium salt is magnesium gluconate.

[0043] In one embodiment, the composition is nicotine-free.

[0044] In one embodiment, the composition is tobacco-free.

[0045] In another aspect, provided is a composition in a meltable form configured for use in the oral cavity, comprising at least one active ingredient selected from the group consisting of caffeine, taurine, GABA, theanine, tryptophan, vitamin B6, vitamin B12 (or other B vitamins), vitamin C, lemon balm extract, carrot, citicoline, sunflower lecithin, and combinations thereof; a sugar alcohol; and a lipid, wherein the meltable form comprises the composition as a homogenous mixture.

[0046] In one embodiment, the sugar alcohol is present in an amount of about 35 to about 55% by weight, based on the total weight of the composition; and the lipid is present in an amount of about 35 to about 50% by weight, based on the total weight of the composition. In one embodiment, the lipid has a melting point of about 29° C. or higher. In one embodiment, the lipid has a melting point of about 36° C. to about 45° C. In one embodiment, the lipid is an oil selected from the group consisting of palm oil, palm kernel oil, soybean oil, sunflower oil, coconut oil, cottonseed oil, and combinations thereof, and the oil may be hydrogenated, partially hydrogenated, or non-hydrogenated.

[0047] In one embodiment, the sugar alcohol is isomalt, erythritol, sorbitol, arabitol, ribitol, maltitol, dulcitol, iditol, mannitol, xylitol, lactitol or combinations thereof. In one embodiment, the sugar alcohol is isomalt.

[0048] In one embodiment, the at least one active ingredient comprises caffeine.

[0049] In one embodiment, the at least one active ingredient includes theanine.

[0050] In one embodiment, the at least one active ingredient includes taurine.

[0051] In one embodiment, the at least one active ingredient includes GABA.

[0052] In one embodiment, the at least one active ingredient comprises tryptophan.

[0053] In one embodiment, the at least one active ingredient includes vitamin B6, vitamin B12, or both, for example, about 0.008% to about 0.07% total by weight of vitamins B6 and B12.

[0054] In one embodiment, the at least one active ingredient comprises Vitamin C.

[0055] In one embodiment, the at least one active ingredient includes ginseng.

[0056] In one embodiment, the at least one active ingredient comprises lemon balm extract.

[0057] In one embodiment, the at least one active ingredient comprises a combination of caffeine, theanine, and optionally ginseng. In one embodiment, caffeine is present in an amount of about 2 to about 6% by weight based on the total weight of the composition; theanine is present in an amount of about 2 to about 4% by weight based on the total weight of the composition; and ginseng, if present, is in an amount of about 0.3 to about 0.5% by weight based on the total weight of the composition.

[0058] In one embodiment, the composition further comprises citicoline or sunflower lecithin.

[0059] In one embodiment, at least a portion of the caffeine is present in encapsulated form.

[0060] In one embodiment, the at least one active ingredient comprises a combination of theanine, gamma aminobutyric acid (GABA), and optionally lemon balm extract. In one embodiment, theanine is present in an amount of about 2 to about 4% by weight, based on the total weight of the composition; GABA is present in an amount of about 3.5 to about 4.5% by weight, based on the total weight of the composition; and lemon balm extract, if present, is in an amount of about 1.5 to about 2.5% by weight, based on the total weight of the composition.

[0061] In one embodiment, the at least one active ingredient comprises theanine and tryptophan. In one embodiment, the at least one active ingredient comprises theanine and vitamins B6, B12, or a combination thereof. In one embodiment, the at least one active ingredient comprises theanine, tryptophan, and vitamins B6, B12, or a combination thereof.

[0062] In one embodiment, the at least one active ingredient comprises a combination of caffeine, taurine, and vitamin C. In one embodiment, caffeine is present in an amount of about 2 to about 6% by weight, based on the total weight of the composition; taurine is present in an amount of about 3.5 to about 4.5% by weight, based on the total weight of the composition; and vitamin C is present in an amount of about 3.5 to about 4.5% by weight, based on the total weight of the composition.

[0063] In one embodiment, at least a portion of the caffeine is present in encapsulated form.

[0064] In one embodiment, the composition further comprises sodium citrate.

[0065] In one embodiment, the composition further comprises at least one additional ingredient selected from sweeteners, salts, flavorings, buffers, emulsifiers, colorants, processing aids, and combinations thereof.

[0066] In one embodiment, the composition further comprises magnesium, for example, in an amount of about 0.1% to about 2% by weight or about 0.2 to about 1% by weight based on elemental magnesium. In one embodiment, the magnesium is in the form of a magnesium salt. In one embodiment, the magnesium salt is magnesium gluconate.

[0067] In one embodiment, the composition is nicotine-free.

[0068] In one embodiment, the composition is tobacco-free.

[0069] In another aspect, provided is a composition comprising at least one active ingredient comprising: a) caffeine in an amount of about 1.5 to about 5% by weight, based on the total weight of the composition; taurine in an amount of about 1.5 to about 6% by weight, based on the total weight of the composition; Vitamin C in an amount of about 2 to about 6% by weight, based on the total weight of the composition; and sodium citrate in an amount of about 1 to about 3% by weight, based on the total weight of the composition; or a combination of b) theanine in an amount of about 1 to about 5% by weight, based on the total weight of the composition; GABA in an amount of about 1.5 to about 6% by weight, based on the total weight of the composition; and Lemon balm extract in an amount of about 1 to about 4% by weight, based on the total weight of the composition; or or a combination of c) caffeine in an amount of about 1.5 to about 6% by weight, based on the total weight of the composition; theanine in an amount of about 1.5 to about 5% by weight, based on the total weight of the composition; Carrot in an amount of about 0.2 to about 0.6% by weight based on the total weight of the composition; and, optionally, Citicoline or sunflower lecithin in an amount of about 0.3 to about 1.5% by weight, based on the total weight of the composition. The present invention relates to a composition in the form of a tablet, sugar or meltable formulation, which is a combination of

[0070] The present disclosure includes, but is not limited to, the following embodiments.

[0071] Embodiment 1: A composition in a chewable form adapted for use in the oral cavity, comprising: at least one active ingredient selected from the group consisting of caffeine, taurine, GABA, theanine, tryptophan, vitamin B6, vitamin B12, vitamin C, lemon balm extract, carrot, citicoline, sunflower lecithin, and combinations thereof; one or more sugar alcohols in an amount of at least 50% by weight based on the total weight of the composition; pectin; and an organic acid, a gelling agent, or both, wherein the composition is a homogenous mixture.

[0072] Embodiment 2: The composition of embodiment 1, wherein the one or more sugar alcohols is a combination of isomalt and maltitol.

[0073] Embodiment 3: The composition of embodiment 1 or 2, comprising isomalt in an amount of about 10 to about 25% by weight, based on the total weight of the composition; maltitol in an amount of about 50 to about 75% by weight, based on the total weight of the composition; and pectin in an amount of about 1 to about 3% by weight, based on the total weight of the composition.

[0074] Embodiment 4: The composition of any one of embodiments 1 to 3, wherein the organic acid is citric acid.

[0075] Embodiment 5: The composition of any one of embodiments 1-4, wherein the at least one active ingredient comprises a combination of caffeine, theanine, and optionally ginseng.

[0076] Embodiment 6: The composition of any one of embodiments 1 to 5, wherein caffeine is present in an amount of about 1 to about 4% by weight, based on the total weight of the composition; theanine is present in an amount of about 1 to about 4% by weight, based on the total weight of the composition; and carrot is present in an amount of about 0.1 to about 0.6% by weight, based on the total weight of the composition.

[0077] Embodiment 7: The composition of any one of embodiments 1-6, further comprising citicoline or sunflower lecithin.

[0078] Embodiment 8: The composition of any one of embodiments 1-4, wherein the at least one active ingredient comprises a combination of theanine, gamma aminobutyric acid (GABA), and optionally lemon balm extract.

[0079] Embodiment 9: The composition of any one of embodiments 1 to 8, wherein theanine is present in an amount of about 1 to about 3% by weight, based on the total weight of the composition; GABA is present in an amount of about 1.5 to about 4% by weight, based on the total weight of the composition; and lemon balm extract, if present, is in an amount of about 0.25 to about 2% by weight, based on the total weight of the composition.

[0080] Embodiment 10: The composition of any one of embodiments 1 to 4, wherein the at least one active ingredient comprises theanine; theanine and tryptophan; or theanine and one or more of vitamins B6 and B12; optionally tryptophan.

[0081] Embodiment 11: The composition of any one of embodiments 1-4, comprising theanine and one or both of vitamin B6 and vitamin B12.

[0082] Embodiment 12: The composition of any one of embodiments 1-4, wherein the at least one active ingredient comprises a combination of caffeine, taurine, and vitamin C.

[0083] Embodiment 13: The composition of any one of embodiments 1 to 12, wherein caffeine is present in an amount of about 1 to about 4% by weight, based on the total weight of the composition; taurine is present in an amount of about 1 to about 4% by weight, based on the total weight of the composition; and vitamin C is present in an amount of about 1 to about 3% by weight, based on the total weight of the composition.

[0084] Embodiment 14: The composition of any one of embodiments 1 to 13, further comprising trisodium citrate.

[0085] Embodiment 15: The composition of any one of embodiments 1 to 14, further comprising at least one additional ingredient selected from water, sweeteners, salts, flavors, buffers, emulsifiers, colorants, processing aids, and combinations thereof.

[0086] Embodiment 16: The composition of any one of embodiments 1 to 15, which does not contain nicotine.

[0087] Embodiment 17: The composition of any one of embodiments 1 to 16, which does not contain tobacco.

[0088] Embodiment 18: A composition in the form of a tablet adapted for use in the oral cavity, comprising at least one active ingredient selected from the group consisting of caffeine, taurine, GABA, theanine, tryptophan, vitamin B6, vitamin B12, vitamin C, lemon balm extract, carrot, citicoline, sunflower lecithin, and combinations thereof; a glucose-polysaccharide blend; and a sugar alcohol, wherein the tablet form contains the composition as a homogenous mixture.

[0089] Embodiment 19: The composition of embodiment 18, wherein the glucose-polysaccharide blend is present in an amount of about 35 to about 55% by weight, based on the total weight of the composition; and the sugar alcohol is present in an amount of about 30 to about 45% by weight, based on the total weight of the composition.

[0090] Embodiment 20: The composition of embodiment 18 or 19, wherein the sugar alcohol is isomalt, erythritol, sorbitol, arabitol, ribitol, maltitol, dulcitol, iditol, mannitol, xylitol, lactitol or a combination thereof.

[0091] Embodiment 21: The composition of any one of embodiments 18 to 20, wherein the sugar alcohol is isomalt.

[0092] Embodiment 22: The composition of any one of embodiments 18-21, wherein the at least one active ingredient comprises a combination of caffeine, theanine, and optionally ginseng.

[0093] Embodiment 23: The composition of any one of embodiments 18 to 22, wherein caffeine is present in an amount of about 3 to about 5% by weight, based on the total weight of the composition; theanine is present in an amount of about 3 to about 5% by weight, based on the total weight of the composition; and carrot is present in an amount of about 0.4 to about 0.6% by weight, based on the total weight of the composition.

[0094] Embodiment 24: The composition of any one of embodiments 18 to 23, further comprising citicoline or sunflower lecithin.

[0095] Embodiment 25: The composition of any one of embodiments 18-21, wherein the at least one active ingredient comprises a combination of theanine, gamma aminobutyric acid (GABA), and optionally lemon balm extract.

[0096] Embodiment 26: The composition of any one of embodiments 18 to 25, wherein theanine is present in an amount of about 3 to about 5% by weight, based on the total weight of the composition; GABA is present in an amount of about 4 to about 6% by weight, based on the total weight of the composition; and lemon balm extract is present in an amount of about 3 to about 4% by weight, based on the total weight of the composition.

[0097] Embodiment 27: The composition of any one of embodiments 18-21, wherein the at least one active ingredient comprises a combination of caffeine, taurine and vitamin C.

[0098] Embodiment 28: The composition of embodiment 27, wherein caffeine is present in an amount of about 3 to about 5% by weight, based on the total weight of the composition; taurine is present in an amount of about 4 to about 6% by weight, based on the total weight of the composition; and vitamin C is present in an amount of about 4 to about 6% by weight, based on the total weight of the composition.

[0099] Embodiment 29: The composition of embodiment 28, further comprising trisodium citrate.

[0100] Embodiment 30: The composition of any one of embodiments 18 to 21, wherein the at least one active ingredient comprises theanine; theanine and tryptophan; or theanine and one or more of vitamins B6 and B12; optionally tryptophan.

[0101] Embodiment 31: The composition of any one of embodiments 18-21, comprising theanine and one or both of vitamin B6 and vitamin B12.

[0102] Embodiment 32: The composition of any one of embodiments 18 to 31, further comprising at least one additional ingredient selected from sweeteners, salts, flavors, buffers, emulsifiers, colorants, processing aids, and combinations thereof.

[0103] Embodiment 33: The composition of any one of embodiments 18 to 32, which does not contain nicotine.

[0104] Embodiment 34: The composition of any one of embodiments 18 to 33, which does not contain tobacco.

[0105] Embodiment 35: A composition in a meltable form adapted for use in the oral cavity, comprising at least one active ingredient selected from the group consisting of caffeine, taurine, GABA, tryptophan, theanine, vitamin B6, vitamin B12, vitamin C, lemon balm extract, carrot, citicoline, sunflower lecithin, and combinations thereof; a sugar alcohol; and a lipid, wherein the meltable form comprises the composition as a homogenous mixture.

[0106] Embodiment 36: The composition of embodiment 35, wherein the sugar alcohol is present in an amount of about 35 to about 55% by weight, based on the total weight of the composition; and the lipid is present in an amount of about 35 to about 50% by weight, based on the total weight of the composition.

[0107] Embodiment 37: The composition of embodiment 35 or 36, wherein the lipid has a melting point of about 29° C. or higher.

[0108] Embodiment 38: A composition described in any one of embodiments 35 to 37, wherein the lipid has a melting point of about 36°C to about 45°C.

[0109] Embodiment 39: The composition of any one of embodiments 35 to 38, wherein the lipid is an oil selected from the group consisting of palm oil, palm kernel oil, soybean oil, sunflower oil, cottonseed oil, coconut oil, and combinations thereof, and the oil may be hydrogenated, partially hydrogenated or non-hydrogenated.

[0110] Embodiment 40: The composition of any one of embodiments 35 to 38, wherein the sugar alcohol is isomalt, erythritol, sorbitol, arabitol, ribitol, maltitol, dulcitol, iditol, mannitol, xylitol, lactitol or a combination thereof.

[0111] Embodiment 41: The composition of any one of embodiments 35 to 40, wherein the sugar alcohol is isomalt.

[0112] Embodiment 42: The composition of any one of embodiments 35 to 41, wherein the at least one active ingredient comprises a combination of caffeine, theanine, and optionally ginseng.

[0113] Embodiment 43: The composition of embodiment 42, wherein caffeine is present in an amount of about 2 to about 6% by weight, based on the total weight of the composition; theanine is present in an amount of about 2 to about 4% by weight, based on the total weight of the composition; and carrot, if present, is in an amount of about 0.3 to about 0.5% by weight, based on the total weight of the composition.

[0114] Embodiment 44: The composition of embodiment 43, further comprising citicoline or sunflower lecithin.

[0115] Embodiment 45: The composition of embodiment 42, wherein at least a portion of the caffeine is present in encapsulated form.

[0116] Embodiment 46: The composition of any one of embodiments 35-41, wherein the at least one active ingredient comprises a combination of theanine, gamma aminobutyric acid (GABA), and optionally lemon balm extract.

[0117] Embodiment 47: The composition of embodiment 46, wherein theanine is present in an amount of about 2 to about 4% by weight, based on the total weight of the composition; GABA is present in an amount of about 3.5 to about 4.5% by weight, based on the total weight of the composition; and lemon balm extract, if present, is in an amount of about 1.5 to about 2.5% by weight, based on the total weight of the composition.

[0118] Embodiment 48: The composition of any one of embodiments 35 to 41, wherein the at least one active ingredient comprises a combination of caffeine, taurine and vitamin C.

[0119] Embodiment 49: The composition of embodiment 48, wherein caffeine is present in an amount of about 2 to about 6% by weight, based on the total weight of the composition; taurine is present in an amount of about 3.5 to about 4.5% by weight, based on the total weight of the composition; and vitamin C is present in an amount of about 3.5 to about 4.5% by weight, based on the total weight of the composition.

[0120] Embodiment 50: The composition of embodiment 48, wherein at least a portion of the caffeine is present in encapsulated form.

[0121] Embodiment 51: The composition of embodiment 48, further comprising trisodium citrate.

[0122] Embodiment 52: The composition of any one of embodiments 35 to 41, wherein the at least one active ingredient comprises theanine; theanine and tryptophan; or theanine and one or more of vitamins B6 and B12; optionally tryptophan.

[0123] Embodiment 52: The composition of any one of embodiments 35 to 41, comprising theanine and one or both of vitamin B6 and vitamin B12.

[0124] Embodiment 53: The composition of any one of embodiments 35 to 52, further comprising at least one additional ingredient selected from sweeteners, salts, flavors, buffers, emulsifiers, colorants, processing aids, and combinations thereof.

[0125] Embodiment 54: The composition of any one of embodiments 35 to 53, which does not contain nicotine.

[0126] Embodiment 55: The composition of any one of embodiments 35 to 54, which does not contain tobacco.

[0127] Embodiment 56: At least one active ingredient is a) caffeine in an amount of about 1.5 to about 5% by weight, based on the total weight of the composition; taurine in an amount of about 1.5 to about 6% by weight, based on the total weight of the composition; Vitamin C in an amount of about 2 to about 6% by weight, based on the total weight of the composition; and sodium citrate in an amount of about 1 to about 3% by weight, based on the total weight of the composition; or a combination of b) theanine in an amount of about 1 to about 5% by weight, based on the total weight of the composition; GABA in an amount of about 1.5 to about 6% by weight, based on the total weight of the composition; and Lemon balm extract in an amount of about 1 to about 4% by weight, based on the total weight of the composition; or or a combination of c) caffeine in an amount of about 1.5 to about 6% by weight, based on the total weight of the composition; theanine in an amount of about 1.5 to about 5% by weight, based on the total weight of the composition; Carrot in an amount of about 0.2 to about 0.6% by weight based on the total weight of the composition; and, optionally, Citicoline or sunflower lecithin in an amount of about 0.3 to about 1.5% by weight, based on the total weight of the composition. The composition of any one of embodiments 1, 18, or 35, which is a combination of:

[0128] Embodiment 57: The composition of any one of embodiments 1 to 56, further comprising magnesium, e.g., in an amount of about 0.1% to about 2% by weight or about 0.2 to about 1% by weight based on elemental magnesium.

[0129] These and other features, aspects and advantages of the present disclosure will become apparent upon reading the following detailed description. The present invention includes any combination of two, three, four or more of the above-described embodiments, including any combination of two, three, four or more features or elements described in this disclosure, whether or not such features or elements are expressly combined with the description of a specific embodiment herein. Because this disclosure is intended to be read in aggregate, it should be considered that any separate features or elements of the disclosed invention are intended to be combined in any of its various aspects and embodiments, unless the context clearly indicates otherwise. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0130] The present disclosure provides a composition adapted for use in the oral cavity, comprising at least one active ingredient and one or more fillers. The one or more fillers generally comprise a sugar alcohol or a combination of sugar alcohols. The at least one active ingredient may comprise one or more botanical materials, stimulants, amino acids, vitamins, antioxidants, nicotine components, cannabinoids, cannabimimetic, terpenes, pharmaceutical agents, or combinations thereof. The composition may be in a chewable form, a tablet form, or a meltable form.

[0131] The present disclosure will now be described more fully below with reference to exemplary embodiments thereof. These exemplary embodiments are provided so that this disclosure will be thorough and complete, and will fully convey the scope of the disclosure to those skilled in the art. Indeed, the present disclosure may be embodied in many different forms, and should not be construed as limited to the embodiments set forth herein, but rather, these embodiments are provided so that this disclosure will satisfy applicable legal requirements. As used in this specification and claims, the singular forms "a," "an," and "the" include plural referents unless the context clearly dictates otherwise. References to "dry weight percent" or "dry weight basis" refer to weight based on dry ingredients (i.e., all ingredients except water). References to "wet weight" refer to the weight of the composition including water. Unless otherwise indicated, references to "weight percent" of a composition reflect the total wet weight of the composition (i.e., including water).

[0132] The compositions described herein comprise at least one active ingredient and one or more fillers.In some embodiments, the compositions may further comprise binders, organic acids, water, sweeteners, salts, flavors, buffers, emulsifiers, colorants, processing aids, and combinations thereof.The relative amounts of various components in the composition may vary and are typically selected to provide the desired sensory and performance attributes for the oral composition.Examples of individual components of the composition are described herein below.

[0133] Filler The compositions described herein include one or more fillers, which can fulfill a number of functions, such as improving certain organoleptic properties, such as texture and mouthfeel, improving the cohesiveness or compressibility of the product, etc.

[0134] The amount of filler may vary, but is typically greater than about 20% by weight of the composition, up to about 75% by weight, based on the total weight of the composition. A typical range of filler in the composition may be about 20 to about 75% by weight, for example, about 20, about 25, or about 30 to about 35, about 40, about 45, or about 50% by weight (e.g., about 20 to about 50% by weight or about 25 to about 45% by weight), based on the total weight of the composition. In certain embodiments, the amount of filler is at least about 20% by weight, for example, at least about 25% or at least about 30% or at least about 35% or at least about 40% by weight, based on the total weight of the composition.

[0135] Generally, the filler is a porous granular material and is cellulosic. For example, suitable fillers are any non-tobacco plant material or derivatives thereof, including cellulosic materials from such sources. Examples of cellulosic non-tobacco plant materials include grains (e.g., sorghum, oats, barley, rye, buckwheat, etc.), sugar beet (e.g., FIBREX® brand filler available from International Fiber Corporation), bran fibers, and mixtures thereof. Non-limiting examples of derivatives of non-tobacco plant materials include starch (e.g., from potato, wheat, rice, corn), natural cellulose, and modified cellulose materials. Additional examples of potential fillers include maltodextrin, dextrose, calcium carbonate, calcium phosphate, lactose, mannitol, xylitol, and sorbitol. Combinations of fillers can also be used.

[0136] "Starch" as used herein can refer to pure starch, modified starch or starch derivatives from any source. Starch is typically present in granular form in almost all green plants and in various types of plant tissues and organs (e.g. seeds, leaves, rhizomes, roots, tubers, shoots, fruits, grains and stems). Starch can vary in composition and granular shape and size. Often, starches from different sources have different chemical and physical properties. A specific starch can be selected for inclusion in the composition based on the ability of the starch material to impart specific organoleptic properties to the composition. Starch from various sources can be used. For example, the main sources of starch include cereals (e.g. rice, wheat and sorghum) and root vegetables (e.g. potato and cassava). Other examples of starch sources include acorn, arrowroot, arracacha, banana, barley, legumes (e.g., broad bean, lentil, mung bean, pea, chickpea), breadfruit, buckwheat, canna, chestnut, taro, dogtooth violet, kudzu, malanga, millet, oats, oka, yam, sago, sorghum, sweet potato, quinoa, rye, tapioca, taro, tobacco, water chestnut, and yam. Certain starches are modified starches. Modified starches have undergone one or more structural modifications that are often designed to modify their high thermal properties. Some starches have been developed by genetic modification and are considered to be "genetically modified" starches. Other starches are obtained and substantially modified by chemical, enzymatic, or physical means. For example, modified starches can be starches that have been subjected to chemical reactions such as esterification, etherification, oxidation, acid-catalyzed depolymerization (thinning) or oxidation in the presence of base, bleaching, transglycosylation and depolymerization (e.g., dextrinization in the presence of a catalyst), crosslinking, acetylation, hydroxypropylation and / or partial hydrolysis. Enzyme treatments include exposing native starches to enzyme isolates or concentrates, microbial enzymes and / or enzymes endogenous to plant material, for example, amylases present in corn kernels to modify corn starch.Other starches have been modified by thermal treatment, such as pregelatinization, dextrinization and / or cold water swelling. Certain modified starches include phosphated starch, phosphate crosslinked starch, phosphate crosslinked starch esterified with sodium trimetaphosphate, phosphate monoesterified phosphate crosslinked starch, acetylated phosphate crosslinked starch, starch acetate esterified with acetic anhydride, starch acetate esterified with vinyl acetate, acetylated adipate crosslinked starch, acetylated glycerol crosslinked starch, hydroxypropyl starch, hydroxypropylglycerol crosslinked starch and sodium starch octenylsuccinate.

[0137] Additional examples of potential fillers include maltodextrin, dextrose, calcium carbonate, calcium phosphate, lactose, and sugar alcohols. A combination of fillers can also be used. In some embodiments, the filler comprises or is a mixture of glucose and starch-derived polysaccharides. One such suitable mixture of glucose and starch-derived polysaccharides is EMDEX®, available from JRS PHARMA LP, USA, 2981 Route 22, Patterson, NY 12563-2359.

[0138] In some embodiments, the filler comprises one or more sugar alcohols. Sugar alcohols are polyols derived from monosaccharides or disaccharides, having a partially or fully hydrogenated form. Sugar alcohols, for example, have from about 4 to about 20 carbon atoms and include erythritol, arabitol, ribitol, isomalt, maltitol, dulcitol, iditol, mannitol, xylitol, lactitol, sorbitol, and combinations thereof (e.g., hydrogenated starch hydrolysates). Isomalt is an equimolar mixture of two disaccharides, each of which consists of two sugars: glucose and mannitol (α-D-glucopyranoside-1,6-mannitol); and glucose and sorbitol (α-D-glucopyranoside-1,6-sorbitol). In some embodiments, the one or more sugar alcohols comprise isomalt. In some embodiments, the one or more sugar alcohols are isomalt.

[0139] In some embodiments, the bulking agent comprises a combination of isomalt and EMDEX®. In some embodiments, the one or more sugar alcohols is a combination of isomalt and EMDEX®.

[0140] In some embodiments, the one or more sugar alcohols is a combination of two or three sugar alcohols. In some embodiments, the sugar alcohol combination comprises or is isomalt and maltitol.

[0141] The total amount of sugar alcohol may vary, but is typically greater than about 30% and up to about 95% by weight of the composition, based on the total weight of the composition. Typical ranges of sugar alcohol in the composition may be, for example, about 35, about 40, about 45, about 50, or about 55 to about 60, about 65, about 70, about 75, about 80, about 85, about 90, or about 95% by weight. In certain embodiments, the amount of sugar alcohol is at least about 50% by weight, for example, at least about 55% by weight, or at least about 60% or at least about 65% or at least about 70% or at least about 75% or at least about 80% or at least about 85% by weight, based on the total weight of the composition.

[0142] In certain embodiments, the sugar alcohol is isomalt in an amount of about 35 to about 55% by weight, for example, about 35, about 40, or about 45 to about 50 or about 55% by weight, based on the total weight of the composition.

[0143] In certain embodiments, the sugar alcohol is a combination of isomalt in an amount of about 10 to about 25% by weight, e.g., about 10, about 15, about 20 or about 25% by weight; and maltitol in an amount of about 50 to about 75% by weight, e.g., about 50, about 55, about 60, about 65% by weight, about 70, about 75% by weight.

[0144] In certain embodiments, the bulking agent is a combination of isomalt in an amount of about 30 to about 50% by weight, e.g., about 30, about 35, about 40, about 45 or about 50% by weight, based on the total weight of the composition; and a glucose-polysaccharide blend (e.g., EMDEX®) in an amount of about 35 to about 55% by weight, e.g., about 35, about 40, about 45 or about 50% by weight, based on the total weight of the composition.

[0145] Lipids In some embodiments, the composition comprises a lipid. Such compositions, in some embodiments, can be described as "meltable" or "melting" compositions, as further described herein below. When present, the lipid of the composition is typically a fat, oil or waxy substance derived from animal or plant materials (i.e., fats derived from plants), and typically comprises mostly triglycerides with lesser amounts of free fatty acids and mono- or diglycerides. In certain embodiments, the lipid is solid or semi-solid at room temperature (i.e., 25°C) and is capable of at least partially liquefying (i.e., "melting") when exposed to the temperature of the user's mouth. Exemplary fats derived from plants are composed primarily of saturated or unsaturated fatty acid chains (the majority of which are linked in triglyceride structures) having a carbon length of about 10 to about 26 carbon atoms, or about 14 to about 20 carbon atoms, or about 14 to about 18 carbon atoms.

[0146] In some embodiments, the lipid comprises an oil, particularly a food grade oil, including fractionated oils. Such oils include, but are not limited to, vegetable oils (e.g., acai oil, almond oil, amaranth oil, apricot kernel oil, apple seed oil, argan oil, avocado oil, babassu oil, beech nut oil, bean oil, bitter melon oil, black seed oil, black currant seed oil, borage seed oil, Borneo tallow nut oil, gourd oil, Brazil nut oil, buffalo gourd oil, butternut squash seed oil, Cape chestnut oil, canola oil, carob cashew oil, cocoa butter, cocklebur oil, coconut oil, corn oil, coffea palm oil, coriander seed oil, cottonseed oil, date seed oil, dika oil, egusi seed oil, evening primrose oil, flaxseed oil, lin ... oil), grape seed oil, grapefruit seed oil, hazelnut oil, hemp oil, kapok seed oil, kenaf seed oil, lallemantia oil, lemon oil, linseed oil, macadamia oil, mafra oil, marula oil, meadowfoam seed oil, mongongo nut oil, mustard oil, niger seed oil, nutmeg butter, okra seed oil, olive oil, orange oil, palm oil, papaya seed oil, groundnut oil, pecan oil, perilla seed oil, perilla seed oil, oyster seed oil, pequi oil, pili nut oil, pine nut oil, pistachio oil, pomegranate seed oil, poppy seed oil, prakashi oil, prune kernel oil, pumpkin seed oil, quinoa oil, ramtil oil, rapeseed oil, rice bran oil, royle oil oil, sacha inchi oil, safflower oil, mexican selaginella oil, seje oil, sesame oil, shea butter, soybean oil, sunflower oil, tarramilla oil, tea seed oil, thistle oil, tiger nut oil, tobacco seed oil, tomato seed oil, walnut oil, watermelon seed oil, wheat germ oil, and combinations thereof), animal oils (e.g., beef fat, buffalo fat, sheep fat, goat fat, porcine fat, lard, camel fat, tallow, liquid margarine, fish oil, fish liver oil, whale oil, seal oil, and combinations thereof), and mineral oils.

[0147] In certain embodiments, the plant-derived fats of the present disclosure include palm oil, palm kernel oil (including fractionated palm oil), soybean oil, cottonseed oil, and mixtures thereof. In one embodiment, the lipids are blends of palm oil and palm kernel oil. The lipids may be, for example, hydrogenated, partially hydrogenated, or non-hydrogenated. Exemplary embodiments of lipids can be purchased under the trade names CEBES®, CISAO®, or CONFAO® available from AarhusKarlshamn USA Inc.

[0148] The melting point of the lipid is typically about 29° C. or higher, for example, about 29° C. to about 49° C., or about 36° C. to about 45° C., or about 38° C. to about 41° C. In some embodiments, the use of lipids with melting points below about 36° C. is not advantageous due to possible melting during storage or handling of the product. One test for determining the melting point of lipids is the Mettler dropping point method (ASTM D3954-15, Standard Test Method for Dropping Point of Waxes, ASTM International, West Conshohocken, PA, 2015, www.astm.org.).

[0149] When present, the amount of lipid in the composition may vary. In certain embodiments, the amount of lipid is at least about 10 percent, at least about 20 percent, or at least about 30 percent based on the dry weight of the composition. In certain embodiments, the amount of lipid is less than about 70 percent, less than about 60 percent, or less than about 50 percent by weight based on the dry weight of the composition. Examples of weight ranges of lipid include about 10 to about 70 percent by dry weight, such as about 35 to about 50 percent by dry weight. In some embodiments, the amount of lipid is about 35, about 40, about 45, or about 50 percent by weight of the total composition.

[0150] In some embodiments, the composition comprises lipid. In one embodiment, the lipid is an oil selected from the group consisting of palm oil, palm kernel oil, soybean oil, sunflower oil, cottonseed oil, coconut oil, and combinations thereof, and the oil may be hydrogenated, partially hydrogenated, or non-hydrogenated. In one embodiment, the lipid is a medium hardness transhydrogenated filling fat such as Confao® 5 available from AarhusKarlshamn USA Inc., 131 Marsh Street, Port Newark, NJ 07114.

[0151] active ingredient The compositions disclosed herein include one or more active ingredients. As used herein, "active ingredient" refers to one or more substances belonging to any of the following classes: API (active pharmaceutical ingredient), food additive, natural medicine, and naturally occurring substances that may have effects on humans. Examples of active ingredients include any ingredient known to affect one or more biological functions in the body, such as ingredients that provide pharmacological activity or other direct action in the diagnosis, cure, mitigation, treatment, or prevention of disease, or affect the structure or any function of the human body (e.g., provide a stimulant effect in the central nervous system, have an energizing effect, an antipyretic or analgesic effect, or another beneficial effect in the body). In some embodiments, the active ingredient may be of the type commonly referred to as a dietary supplement, nutraceutical, "phytochemical," or "functional food." These types of additives are sometimes defined in the art as encompassing substances that are typically available from naturally occurring sources (e.g., botanical materials) that provide one or more beneficial biological effects (e.g., health promotion, disease prevention, or other medicinal properties), but are not classified or regulated as drugs.

[0152] Non-limiting examples of active ingredients include those falling into the categories of botanical ingredients, stimulants, amino acids, nicotine ingredients, and / or pharmaceutical ingredients, nutritional ingredients, and medicinal ingredients (e.g., vitamins such as A, B3, B6, B12, and C, and / or cannabinoids such as tetrahydrocannabinol (THC) and cannabidiol (CBD)). Each of these categories is further described herein below. The particular choice of active ingredient will vary depending on the desired flavor, texture, and desired attributes of a particular product.

[0153] The specific percentage of active ingredients present varies depending on the desired characteristics of a particular product. Typically, the active ingredient or combination thereof is present at a total concentration of at least about 0.001% by weight of the composition, for example, at a total concentration ranging from about 0.001% to about 20%. In some embodiments, the active ingredient or combination of active ingredients is present at a concentration of about 0.1% w / w to about 10% by weight, for example, about 0.5% w / w to about 10%, about 1% to about 10%, about 1% to about 5% by weight, based on the total weight of the composition. In some embodiments, the active ingredient or combination of active ingredients is present at a concentration of about 0.001%, about 0.01%, about 0.1%, or about 1%, up to about 20% by weight based on the total weight of the composition, for example, about 0.001%, about 0.002%, about 0.003%, about 0.004%, about 0.005%, about 0.006%, about 0.007%, about 0.008%, about 0.009%, about 0.01%, about 0.02%, about 0.03%, about 0.04%, about 0.05%, about 0.06%, It is present in a concentration of about 0.07% by weight, about 0.08% by weight, about 0.09% by weight, about 0.1% by weight, about 0.2% by weight, about 0.3% by weight, about 0.4% by weight, about 0.5% by weight, about 0.6% by weight, about 0.7% by weight, about 0.8% by weight or about 0.9% by weight to about 1% by weight, about 2% by weight, about 3% by weight, about 4% by weight, about 5% by weight, about 6% by weight, about 7% by weight, about 8% by weight, about 9% by weight, about 10% by weight, about 11% by weight, about 12% by weight, about 13% by weight, about 14% by weight, about 15% by weight, about 16% by weight, about 17% by weight, about 18% by weight, about 19% by weight or about 20% by weight. More suitable ranges for specific active ingredients are given herein below.

[0154] Botanical In some embodiments, the active ingredient comprises a botanical ingredient. As used herein, the term "botanical ingredient" or "botanical" refers to any plant or fungal derived material, including plant material in its natural form and plant material derived from natural plant material, such as an extract or isolate derived from the plant material, or treated plant material (e.g., plant material that has been heat treated, fermented, bleached, or otherwise treated to alter the physical and / or chemical properties of the material). For purposes of this disclosure, "botanical" includes, but is not limited to, "herbal material," which refers to seed-bearing plants (e.g., tea or tisane) that do not develop persistent woody tissue and are often valued for their medicinal or sensory qualities. Reference to botanical material as "non-tobacco" is intended to exclude tobacco material (i.e., does not include any Nicotiana species). In some embodiments, the compositions disclosed herein can be characterized as being free of any tobacco material (e.g., any embodiment disclosed herein can be completely or substantially free of any tobacco material). By "substantially free," it is meant that no tobacco material has been intentionally added. For example, certain embodiments can be characterized as having less than 0.001% tobacco by weight, or 0.0001% or 0% tobacco by weight.

[0155] If present, botanicals are typically at a concentration of about 0.01% w / w to about 10% by weight based on the total weight of the composition, for example, about 0.01% w / w, about 0.05%, about 0.1% or about 0.5% to about 1%, about 2%, about 3%, about 4%, about 5%, about 6%, about 7%, about 8%, about 9% or about 10%, about 11%, about 12%, about 13%, about 14% or about 15% by weight.

[0156] Botanical materials useful in the present disclosure may include any of the compounds and sources described herein, including, but not limited to, mixtures thereof. Certain botanical materials of this type are sometimes referred to as dietary supplements, nutraceuticals, "phytochemicals" or "functional foods." Certain botanicals, as plant materials or extracts thereof, find use in traditional herbal medicines and are further described herein.Non-limiting examples of botanicals or botanically derived materials include ashwagandha, Bacopa monniera, baobab, basil, Centella asiatica, bupleurum, chamomile, cherry blossom, chlorophyll, cinnamon, citrus, clove, cocoa, cordyceps, curcumin, damiana, Dorstenia arifolia, Dorstenia odorata, essential oils, eucalyptus, fennel, Galphimia glauca, ginger, Ginkgo biloba, carrots (e.g., Panax ginseng), green tea, Griffonia simplicifolia, and the like. simplicifolia, Guarana, Cannabis sativa, Hemp, Hops, Jasmine, Kaempferia parviflora (Thai ginseng), Kava, Lavender, Lemon balm, Lemongrass, Licorice, Lutein, Maca, Matcha, Nardostachys chinensis, Oil extract of Viola odorata, Peppermint, Quercetin, Resveratrol, Rhizoma gastrodiae, Rhodiola, Rooibos, Rose essential oil, Rosemary, Sceletium tortuosum tortuosum, Schisandra, skullcap, spearmint extract, pepper, terpenes, tisane, turmeric, Turnera aphrodisiaca, valerian, white mulberry and yerba mate.

[0157] In some embodiments, the active ingredient comprises lemon balm. Lemon balm (Melissa officinalis) is a mildly lemon-scented herb from the same family as mint (Lamiaceae). The herb is native to Europe, North Africa and Western Asia. Lemon balm teas and essential oils and extracts are used in traditional and alternative medicine. In some embodiments, the active ingredient comprises lemon balm extract. In some embodiments, the lemon balm extract is present in an amount of about 1 to about 4% by weight, based on the total weight of the composition.

[0158] In some embodiments, the active ingredient comprises ginseng. Ginseng is the root of a plant of the genus Panax, and ginseng is characterized by the presence of the unique steroidal saponin phytochemicals (ginsenosides) and gintonin. Ginseng finds use as a dietary supplement in energy drinks or herbal teas and in traditional medicine. Cultivated species include Korean ginseng (P. ginseng), Chinese ginseng (P. notoginseng), and American ginseng (P. quinquefolius). American ginseng and Korean ginseng vary in the types and amounts of various ginsenosides present. In some embodiments, the ginseng is American ginseng or Korean ginseng. In a specific embodiment, the active ingredient comprises Korean ginseng. In some embodiments, the ginseng is present in an amount of about 0.4 to about 0.6% by weight, based on the total weight of the composition.

[0159] Stimulants In some embodiments, the active ingredient comprises one or more stimulants. As used herein, the term "stimulant" refers to a material that increases the activity of the central nervous system and / or the body, for example, improving focus, cognition, energy, mood, alertness, etc. Non-limiting examples of stimulants include caffeine, theacrine, theobromine, and theophylline. Theacrine (1,3,7,9-tetramethyluric acid) is a purine alkaloid that is structurally related to caffeine and has stimulant, analgesic, and anti-inflammatory effects. The stimulant may be natural, naturally derived, or completely synthetic. For example, certain botanical materials (such as guarana, tea, coffee, cocoa, etc.) may have a stimulant effect, for example, due to the presence of caffeine or related alkaloids, and are therefore "natural" stimulants. "Naturally derived" means that the stimulant (e.g., caffeine, theacrine) is in a purified form outside of its natural (e.g., botanical) matrix. For example, caffeine can be obtained by extraction and purification from botanical sources (e.g., tea). "Fully synthetic" means that the stimulant is obtained by chemical synthesis. In some embodiments, the active ingredient comprises caffeine. In some embodiments, the caffeine is present in an encapsulated form. One example of encapsulated caffeine is Vitashure®, available from Balchem ​​Corp., 52 Sunrise Park Road, New Hampton, NY, 10958.

[0160] When present, the stimulant or combination of stimulants (e.g., caffeine, theacrine, and combinations thereof) is typically present at a concentration of about 0.1% w / w to about 15% by weight based on the total weight of the composition, for example, about 0.1% w / w, about 0.2%, about 0.3%, about 0.4%, about 0.5%, about 0.6%, about 0.7%, about 0.8%, or about 0.9% to about 1%, about 2%, about 3%, about 4%, about 5%, about 6%, about 7%, about 8%, about 9%, about 10%, about 11%, about 12%, about 13%, about 14%, or about 15% by weight. In some embodiments, the composition comprises caffeine in an amount of about 1.5 to about 6% by weight based on the total weight of the composition.

[0161] amino acid In some embodiments, the active ingredient comprises an amino acid. As used herein, the term "amino acid" refers to an organic compound containing an amine (-NH2) and a carboxyl (-COOH) or sulfonic acid (SO3H) functional group with a side chain (R group), which is specific for each amino acid. An amino acid can be proteinogenic or non-proteinogenic. "Proteogenic" means that the amino acid is one of the 12 naturally occurring amino acids found in proteins. Proteinogenic amino acids include alanine, arginine, asparagine, aspartic acid, cysteine, glutamine, glutamic acid, glycine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, and valine. "Non-proteogenic" means that either amino acid is not naturally found in proteins or is not directly produced by intracellular machinery (e.g., is a product of post-translational modification). Non-limiting examples of non-proteinogenic amino acids include gamma aminobutyric acid (GABA), taurine (2-aminoethanesulfonic acid), theanine (L-γ-glutamylethylamide), hydroxyproline, and beta-alanine. In some embodiments, the active ingredient includes theanine. In some embodiments, the active ingredient includes GABA. In some embodiments, the active ingredient includes a combination of theanine and GABA. In some embodiments, the active ingredient is a combination of theanine, GABA, and lemon balm. In some embodiments, the active ingredient includes a combination of theanine and tryptophan. In some embodiments, the active ingredient includes a combination of theanine and one or more B vitamins. In some embodiments, the active ingredient is a combination of caffeine, theanine, and optionally ginseng. In some embodiments, the active ingredient includes taurine. In some embodiments, the active ingredient is a combination of caffeine and taurine.

[0162] Without being bound by any theory of operation, it is believed that certain amino acids, such as theanine, tryptophan, GABA, or taurine, can have a beneficial effect on mood, anxiety levels, concentration, or cognitive performance, especially when combined with other active ingredients, such as caffeine or certain botanicals.

[0163] When present, the amino acid or combination of amino acids (e.g., theanine, taurine, GABA, tryptophan, and combinations thereof) are typically at a concentration of about 0.01% w / w to about 15% by weight, based on the total weight of the composition, for example, about 0.1% w / w, about 0.2%, about 0.3%, about 0.4%, about 0.5%, about 0.6%, about 0.7%, about 0.8%, or about 0.9% to about 1%, about 2%, about 3%, about 4%, about 5%, about 6%, about 7%, about 8%, about 9%, about 10%, about 11%, about 12%, about 13%, about 14%, or about 15% by weight.

[0164] In one embodiment, the at least one active ingredient comprises tryptophan in an amount of about 0.03% to about 1% by weight or about 0.05% to about 0.5% by weight.

[0165] vitamin In some embodiments, the active ingredient comprises a vitamin or a combination of vitamins. As used herein, the term "vitamin" refers to an organic molecule (or set of related molecules) that is an essential micronutrient required for the normal functioning of metabolism in mammals. There are 13 vitamins required for human metabolism, which are vitamin A (as all-trans retinol, all-trans retinyl esters, and all-trans beta-carotene and other provitamin A carotenoids), vitamin B1 (thiamine), vitamin B2 (riboflavin), vitamin B3 (niacin), vitamin B5 (pantothenic acid), vitamin B6 (pyridoxine), vitamin B7 (biotin), vitamin B9 (folic acid or folate), vitamin B12 (cobalamin), vitamin C (ascorbic acid), vitamin D (calciferol), vitamin E (tocopherol and tocotrienol), and vitamin K (quinone). In some embodiments, the active ingredient comprises vitamin C. In some embodiments, the active ingredient is a combination of vitamin C, caffeine, and taurine. In some embodiments, the active ingredient includes one or more of vitamins B6 and B 12. In some embodiments, the active ingredient includes theanine and one or more of vitamins B6 and B 12. If present, a vitamin or combination of vitamins (e.g., vitamin B6, vitamin B12, vitamin E, vitamin C, or combinations thereof) is typically present at a concentration of about 0.0001% to about 6% by weight based on the total weight of the composition, for example, about 0.0001, about 0.001, about 0.01%, about 0.02%, about 0.03%, about 0.04%, about 0.05%, about 0.06%, about 0.07%, about 0.08%, about 0.09% or about 0.1% w / w to about 0.2%, about 0.3%, about 0.4%, about 0.5%, about 0.6%, about 0.7%, about 0.8%, about 0.9%, about 1%, about 2%, about 3%, about 4%, about 5% or about 6% by weight.

[0166] In some embodiments, the active ingredient comprises vitamin B6 in an amount of about 0.008% to about 0.06% by weight or about 0.01% to about 0.04% by weight.

[0167] In some embodiments, the active ingredient comprises vitamin B12 in an amount of about 0.0001% to about 0.007% by weight or about 0.0005% to about 0.001% by weight.

[0168] In some embodiments, the active ingredients include a combination of vitamin B6 and vitamin B12 in a total amount of about 0.008% to about 0.07% by weight.

[0169] Antioxidants In some embodiments, the active ingredient comprises one or more antioxidants. As used herein, the term "antioxidant" refers to a substance that can prevent or inhibit oxidation by halting free radical reactions, slowing or preventing some types of cell damage. Antioxidants can be naturally occurring or synthetic. Naturally occurring antioxidants include those found in foods and botanical materials. Non-limiting examples of antioxidants include certain botanical materials, vitamins, polyphenols, and phenol derivatives.

[0170] Examples of botanical materials with antioxidant properties include, but are not limited to, acai berry, alfalfa, allspice, annatto seed, apricot kernel oil, basil, common mentha, monarda, black pepper, blueberry, borage seed oil, burdock, cacao, calamus root, cathartic vine, catuaba, cayenne pepper, chaga mushroom, chervil, cinnamon, dark chocolate, potato skin, grape seed, carrot, ginkgo biloba, St. John's wort, saw palmetto, green tea, black tea, black cohosh, cayenne, chamomile, cloves, cacao powder, cranberry, dandelion, grapefruit, honeybush, echinacea, garlic, evening primrose, feverfew, ginger, goldensea ash, and others. citrus fruit, hawthorn, hibiscus flower, gynostemma, kava, lavender, licorice, marjoram, milk thistle, mint, oolong tea, beet root, orange, oregano, papaya, mint, peppermint, red clover, rooibos (red or green), rose hips, rosemary, sage, clary sage, savory, spearmint, spirulina, slippery elm bark, sorghum high tannin bran, sorghum high tannin grain, urushi bran, comfrey leaves and root, wolfberries, gotu kola, thyme, turmeric, bearberry, valerian, wild yam root, mung bean, yacon root, yellow dock, yerba mate, yerba santa, bacopa monnieri. monniera, withania somnifera, Yamabushitake and Silybum marianum. Such botanical materials may be provided in fresh or dried form, in essential oils or in the form of extracts. Botanical materials (as well as their extracts) often contain compounds from various classes known to provide antioxidant benefits, such as minerals, vitamins, isoflavones, phytosterols, allyl sulfides, dithiolthiones, isothiocyanates, indoles, lignans, flavonoids, polyphenols and carotenoids.Examples of compounds found in botanical extracts or oils include ascorbic acid, peanut endocarp, resveratrol, sulforaphane, beta-carotene, lycopene, lutein, coenzyme Q, carnitine, quercetin, kaempferol, etc. See, e.g., Santhosh et al., Phytomedicine, 12 (2005), pp. 216-220, which is incorporated herein by reference.

[0171] Non-limiting examples of other suitable antioxidants include citric acid, vitamin E or a derivative thereof, tocopherol, epicatechol, epigallocatechol, epigallocatechol gallate, erythorbic acid, sodium erythorbate, 4-hexylresorcinol, theaflavin, theaflavin monogallate A or B, theaflavin digallate, phenolic acids, glycosides, quercitrin, isoquercitrin, hyperosides, polyphenols, catechol, resveratrol, oleuropein, butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT), tertiary butylhydroquinone (TBHQ), and combinations thereof.

[0172] When present, antioxidants are typically at a concentration of about 0.001% w / w to about 10% by weight based on the total weight of the composition, for example, about 0.001%, about 0.005%, about 0.01% w / w, about 0.05%, about 0.1% or about 0.5% to about 1%, about 2%, about 3%, about 4%, about 5%, about 6%, about 7%, about 8%, about 9% or about 10%.

[0173] Nicotine content In certain embodiments, the active ingredient comprises a nicotine component. By "nicotine component" is meant any form of nicotine (e.g., free base or salt) suitable for providing buccal absorption of at least a portion of the nicotine present. Typically, the nicotine component is selected from the group consisting of nicotine free base and nicotine salt. In some embodiments, the nicotine component is nicotine in its free base form, which can be easily absorbed, for example, in microcrystalline cellulose material forming a microcrystalline cellulose-nicotine carrier complex. See, for example, the discussion of nicotine in free base form in Hansson, US Patent Publication No. 2004 / 0191322, which is incorporated herein by reference.

[0174] In some embodiments, at least a portion of the nicotine component can be utilized in the form of a salt. The nicotine salt can be provided using the types of ingredients and techniques described in U.S. Patent No. 2,033,909 to Cox et al. and Perfetti, Beitrage Tabakforschung Int., 12:43-54 (1983), which are incorporated herein by reference. In addition, nicotine salts are available from sources such as Pfaltz and Bauer, Inc. and K&K Laboratories, Division of ICN Biochemicals, Inc. Typically, the nicotine component is selected from the group consisting of nicotine free base, nicotine salts, such as hydrochloride, dihydrochloride, monotartrate, bitartrate, sulfate, salicylate, and nicotine zinc chloride.

[0175] In some embodiments, at least a portion of the nicotine may be in the form of a resin complex of nicotine, where the nicotine is bound to an ion exchange resin such as nicotine polacrilex, for example, nicotine bound to a polymethacrylic acid such as Amberlite IRP64, Purolite C115HMR, or Doshion P551. See, for example, U.S. Patent No. 3,901,248 to Lichtneckert et al., which is incorporated herein by reference. Another example is a nicotine-polyacrylcarbomer complex, such as with Carbopol 974P. In some embodiments, the nicotine may be present in the form of a nicotine polyacryl complex.

[0176] Typically, the nicotine component (calculated as the free base), if present, is at a concentration of at least about 0.001% by weight of the composition, e.g., at a concentration ranging from about 0.001% to about 10%. In some embodiments, the nicotine component is typically present at a concentration of about 0.1% w / w to about 10% by weight, e.g., about 0.1% w / w, about 0.2%, about 0.3%, about 0.4%, about 0.5%, about 0.6%, about 0.7%, about 0.8%, or about 0.9% to about 1%, about 2%, about 3%, about 4%, about 5%, about 6%, about 7%, about 8%, about 9%, or about 10% by weight, calculated as the free base, based on the total weight of the composition. In some embodiments, the nicotine component is present at a concentration of from about 0.1% w / w to about 3% by weight, calculated as the free base, based on the total weight of the composition, e.g., from about 0.1% w / w to about 2.5%, from about 0.1% to about 2.0%, from about 0.1% to about 1.5%, or from about 0.1% to about 1% by weight.

[0177] In some embodiments, the products or compositions of the present disclosure can be characterized as being free of any nicotine components (e.g., any embodiment disclosed herein can be completely or substantially free of any nicotine components). By "substantially free" it is meant that nicotine has not been intentionally added beyond trace amounts that may be naturally present, for example, in botanical materials. For example, certain embodiments can be characterized as having less than 0.001% nicotine by weight, or 0.0001% or 0% nicotine by weight, calculated as the free base.

[0178] In some embodiments, the active ingredient comprises a nicotine component (e.g., any product or composition of the present disclosure, in addition to comprising any active ingredient or combination of active ingredients disclosed herein, can further comprise a nicotine component).

[0179] Cannabinoids In some embodiments, the active ingredient comprises one or more cannabinoids.As used herein, the term "cannabinoid" refers to a class of diverse chemical compounds that act on cannabinoid receptors in cells, also known as the endocannabinoid system, to modify the release of neurotransmitters in the brain.The ligands for these receptor proteins include endocannabinoids that are naturally produced in the body by animals; phytocannabinoids found in cannabis; and synthetic cannabinoids that are artificially produced. Cannabinoids found in cannabis include, but are not limited to, cannabigerol (CBG), cannabichromene (CBC), cannabidiol (CBD), tetrahydrocannabinol (THC), cannabinol (CBN), cannabinodiol (CBDL), cannabicyclol (CBL), cannabivarin (CBV), tetrahydrocannabivarin (THCV), cannabidivarin (CBDV), cannabichromevarin (CBCV), cannabigerovarin (CBGV), cannabigerol monomethyl ether (CBGM), cannabinerolic acid, cannabidiolic acid (CBDA), cannabinol propyl variant (CBNV), cannabiditriol (CBO), tetrahydrocannabinolic acid (THCA), and tetrahydrocannabivarinic acid (THCV A). In certain embodiments, the cannabinoid is selected from tetrahydrocannabinol (THC), the main psychoactive compound in cannabis, and cannabidiol (CBD), another major component of the plant, but lacking psychoactivity. All of the above compounds can be used in the form of isolates from plant material or can be derived synthetically.

[0180] Alternatively, the active ingredient may be a cannabimimetic, which is a class of compounds derived from plants other than cannabis that have biological effects on the endocannabinoid system similar to cannabinoids. Examples include yangonin, alpha-amyrin or beta-amyrin (also classified as terpenes), cyanidin, curcumin (turmeric), catechin, quercetin, salvinorin A, N-acylethanolamines and N-alkylamide lipids.

[0181] If present, the cannabinoid (e.g., CBD) or cannabimimetic will typically be at a concentration of at least about 0.1% by weight of the composition, for example at a concentration in the range of about 0.1% to about 30%, for example about 0.1%, about 0.2%, about 0.3%, about 0.4%, about 0.5%, about 0.6%, about 0.7%, about 0.8% or about 0.9% to about 1%, about 2%, about 3%, about 4%, about 5%, about 6%, about 7%, about 8%, about 9%, about 10%, about 15%, about 20% or about 30% by weight based on the total weight of the composition.

[0182] Terpenes Active ingredients suitable for use in the present disclosure can also be classified as terpenes, many of which are associated with biological effects, such as sedative effects. Terpenes have the general formula (C5H8): n It is understood that the terpene has the formula: and includes monoterpenes, sesquiterpenes, and diterpenes. Terpenes can be acyclic, monocyclic, or bicyclic in structure. Some terpenes, when used in combination with cannabinoids or cannabimimetics, produce an entourage effect. Examples include beta-caryophyllene, linalool, limonene, beta-citronellol, linalyl acetate, pinene (alpha or beta), geraniol, carvone, eucalyptol, menthone, iso-menthone, piperitone, myrcene, beta-bourbonene, and germacrene, which can be used alone or in combination.

[0183] Pharmaceutical ingredients In some embodiments, the active ingredient comprises an active pharmaceutical ingredient (API). The API can be any known agent suitable for therapeutic, prophylactic or diagnostic use. These can include, for example, synthetic organic compounds, proteins and peptides, polysaccharides and other sugars, lipids, phospholipids, inorganic compounds (e.g., magnesium, selenium, zinc, nitrates), neurotransmitters or their precursors (e.g., serotonin, 5-hydroxytryptophan, oxytriptan, acetylcholine, dopamine, melatonin) and nucleic acid sequences that have therapeutic, prophylactic or diagnostic activity. Non-limiting examples of APIs include analgesics and antipyretics (e.g., acetylsalicylic acid, acetaminophen, 3-(4-isobutylphenyl)propanoic acid), phosphatidylserine, myo-inositol, docosahexaenoic acid (DHA, omega-3), arachidonic acid (AA, omega-6), S-adenosylmethionine (SAM), beta-hydroxy-beta-methylbutyrate (HMB), citicoline (cytidine-5'-diphosphate-choline), and cotinine. In some embodiments, the active ingredient includes citicoline. In some embodiments, the active ingredient is a combination of citicoline, caffeine, theanine, and carrot. In some embodiments, the active ingredient includes sunflower lecithin. In some embodiments, the active ingredient is a combination of sunflower lecithin, caffeine, theanine, and carrot.

[0184] The amount of API may vary. For example, when present, the API is typically present at a concentration of about 0.001% w / w to about 10% by weight, such as about 0.01, about 0.02, about 0.03, about 0.04, about 0.05, about 0.06, about 0.07, about 0.08, about 0.09, about 0.1% w / w, about 0.2, about 0.3, about 0.4, about 0.5, about 0.6, about 0.7, about 0.8, about 0.9, or about 1 to about 2, about 3, about 4, about 5, about 6, about 7, about 8, about 9, or about 10% by weight, based on the total weight of the composition.

[0185] In some embodiments, the composition is substantially free of any API. "Substantially free of any API" means that the composition does not contain, and specifically excludes, the presence of any API as defined herein, such as any Food and Drug Administration (FDA) approved therapeutic agent intended to treat any medical condition.

[0186] In certain embodiments, the active ingredient is selected from the group consisting of caffeine, taurine, GABA, theanine, tryptophan, vitamin B6, vitamin B12, vitamin C, lemon balm extract, carrot, citicoline, sunflower lecithin, and combinations thereof. For example, the active ingredient may include a combination of caffeine, theanine, and optionally carrot. In another embodiment, the active ingredient includes a combination of theanine, gamma aminobutyric acid (GABA), and optionally lemon balm extract. In a further embodiment, the active ingredient includes one or more of theanine, theanine and tryptophan, theanine and B vitamins B6 and B12, or tryptophan, theanine, and B vitamins B6 and B12. In yet a further embodiment, the active ingredient includes a combination of caffeine, taurine, and vitamin C, and optionally further includes one or more B vitamins (e.g., vitamin B6 or B12). A magnesium salt (eg, magnesium gluconate) can be added to any of the above combinations, particularly those that also include theanine.

[0187] water The moisture content (e.g., water content) of the composition can vary depending on the desired properties prior to consumer use of the product. Typically, the composition contains less than about 60% water by weight, generally about 1 to about 60% water by weight, such as about 5 to about 55% by weight, about 10 to about 50% by weight, about 20 to about 45% by weight, or about 25 to about 40% by weight of water, including at least about 5% by weight, at least about 10% by weight, at least about 15% by weight, and at least about 20% by weight of water, prior to insertion into the oral cavity of the user.

[0188] salt In some embodiments, the composition includes a salt (e.g., an alkali metal salt), typically utilized in an amount sufficient to provide the composition with the desired sensory attributes. Non-limiting examples of suitable salts include sodium chloride, potassium chloride, ammonium chloride, powdered salt, sodium acetate, sodium citrate, calcium citrate, and the like. In some embodiments, the salt is sodium chloride, ammonium chloride, or a combination thereof. In some embodiments, the salt is trisodium citrate, calcium citrate, or a combination thereof.

[0189] If present, representative amounts of salts will be about 0.1% by weight or more, about 0.5% by weight or more, about 1.0% by weight or more, or about 1.5% by weight or more, but will typically comprise about 10% by weight or less, or about 7.5% by weight or less, or about 5% by weight or less (e.g., from about 0.1 to about 5% by weight) of the total weight of the composition.

[0190] sweetener To improve the sensory properties of the composition according to the present disclosure, one or more sweeteners may be added. The sweetener may be any sweetener or combination of sweeteners, in natural or artificial form or as a combination of natural and artificial sweeteners. Examples of natural sweeteners include fructose, sucrose, glucose, maltose, isomaltulose, mannose, galactose, lactose, stevia, honey, etc. Examples of artificial sweeteners include sucralose, maltodextrin, saccharin, aspartame, acesulfame K, neotame, etc. In some embodiments, the sweetener comprises one or more sugar alcohols. Sugar alcohols are polyols derived from monosaccharides or disaccharides, having a partially or fully hydrogenated form. Sugar alcohols, for example, have from about 4 to about 20 carbon atoms and include erythritol, arabitol, ribitol, isomalt, maltitol, dulcitol, iditol, mannitol, xylitol, lactitol, sorbitol, and combinations thereof (e.g., hydrogenated starch hydrolysates).In some embodiments, the sweetener is sucralose, acesulfame K, or combinations thereof.

[0191] When present, the sweetener or combination of sweeteners may comprise from about 0.01 to about 20% or more by weight of the composition, for example, from about 0.01 to about 0.1, from about 0.1 to about 1, from about 1 to about 5, from about 5 to about 10, or from about 10 to about 20% by weight, based on the total weight of the composition. In some embodiments, the combination of sweeteners is present at a concentration of from about 0.01 to about 0.1% by weight of the composition, for example, about 0.01, about 0.02, about 0.03, about 0.04, about 0.05, about 0.06, about 0.07, about 0.08, about 0.09, or about 0.1% by weight of the composition. In some embodiments, the sweetener combination is present at a concentration of about 0.1 to about 0.5% by weight of the composition, such as about 0.1, about 0.2, about 0.3, about 0.4 or about 0.5% by weight of the composition, hi some embodiments, the sweetener combination is present at a concentration of about 1 to about 3% by weight of the composition.

[0192] Flavoring Agent In some embodiments, the composition comprises a flavoring agent. As used herein, a "flavoring agent", "flavor" or "flavoring agent" is any flavorful or aromatic substance capable of modifying the sensory attributes associated with an oral product. Examples of sensory attributes that may be modified by a flavoring agent include taste, texture, moistness, cool / warmth, and / or aromatic / fragrant. Flavoring agents may be natural or synthetic, and the flavor characteristics imparted thereby may be described as, but are not limited to, fresh, sweet, herbal, confectionery, floral, fruity, or spicy. Specific flavor types include, but are not limited to, vanilla, coffee, chocolate / cocoa, cream, mint, spearmint, menthol, peppermint, mung bean, eucalyptus, lavender, cardamom, nutmeg, cinnamon, clove, cascarilla, sandalwood, honey, jasmine, ginger, anise, sage, licorice, lemon, orange, apple, peach, lime, cherry, strawberry, trigeminal sensates, terpenes, and any combination thereof. See also Leffingwell et al., Tobacco Flavoring for Smoking Products, RJ Reynolds Tobacco Company (1972), which is incorporated herein by reference. Flavoring agents may also include ingredients considered to be moistening, cooling, or smoothing agents, such as eucalyptus. These flavors can be provided neat (i.e., alone) or in composites and can be available as concentrates or flavor packets (e.g., spearmint and menthol, orange and cinnamon, lime, pineapple, etc.). Representative types of ingredients are also described in U.S. Patent No. 5,387,416 to White et al.; U.S. Patent Application Publication No. 2005 / 0244521 to Strickland et al.; and PCT Application Publication No. WO 05 / 041699 to Quinter et al., each of which is incorporated herein by reference. In some instances, the flavoring agent can be provided in a spray-dried or liquid form.

[0193] The amount of flavoring utilized in the composition can vary but is typically up to about 10% by weight, with certain embodiments being characterized by a flavoring content of at least about 0.1% by weight, e.g., from about 0.5 to about 10% by weight, from about 1 to about 5% by weight, or from about 2 to about 4% by weight, based on the total weight of the composition.

[0194] Taste modifiers To improve the organoleptic properties of the compositions disclosed herein, the compositions may include one or more taste modifiers ("taste modifiers") of the compositions that can function, for example, to mask, modify, block or improve the flavors described herein. Non-limiting examples of such taste modifiers include analgesic or anesthetic herbs, spices and flavors that produce a perceived sensation of coolness (e.g., menthol, eucalyptus, mint), warmth (e.g., cinnamon) or pain (e.g., capsaicin). Certain taste modifiers fall into two or more overlapping categories.

[0195] In some embodiments, the taste modifier modifies one or more of the following tastes: bitter, sweet, salty, or sour. In some embodiments, the taste modifier targets pain receptors. In some embodiments, the composition includes an active ingredient that has a bitter taste and a taste modifier that masks or blocks the perception of the bitter taste. In some embodiments, the taste modifier is a substance that targets pain receptors (e.g., vanilloid receptors) in the user's oral cavity, for example, masking the bitter taste of another ingredient (e.g., an active ingredient). Suitable taste modifiers include, but are not limited to, capsaicin, gamma aminobutyric acid (GABA), adenosine monophosphate (AMP), lactisol, or combinations thereof.

[0196] When present, representative amounts of taste modifiers are about 0.01% by weight or more, about 0.1% by weight or more, or about 1.0% by weight or more, but typically comprise less than about 10% by weight of the total weight of the composition (e.g., about 0.01%, about 0.05%, about 0.1%, or about 0.5% to about 1%, about 5%, or about 10% by weight of the total weight of the composition).

[0197] Binder The binder (or combination of binders) can be utilized in a sufficient amount to provide the composition with desired physical attributes and physical integrity in certain embodiments, and the binder often also functions as a thickening or gelling agent. Typical binders can be organic or inorganic or combinations thereof. Representative binders include cellulose derivatives (e.g., cellulose ethers), povidone, sodium alginate, starch-based binders, pectin, gums, carrageenan, pullulan, zein, and the like, and combinations thereof. In some embodiments, the binder includes pectin or carrageenan, or combinations thereof.

[0198] The amount of binder utilized in the composition can vary based on the binder and the desired composition properties, but is typically up to about 30% by weight, with certain embodiments being characterized by a binder content of at least about 0.1% by weight, e.g., from about 0.5 to about 30% by weight, or from about 1 to about 10% by weight, based on the total weight of the composition.

[0199] In certain embodiments, the binder comprises a gum, such as a natural gum. As used herein, natural gum refers to a polysaccharide material of natural origin that has binding properties and is also useful as a thickening or gelling agent. Representative natural gums of plant origin that are typically water-soluble to some extent include xanthan gum, guar gum, gum arabic, gum ghatti, gum tragacanth, gum karaya, locust bean gum, gellan gum, and combinations thereof. When present, natural gum binder materials are typically present in an amount of up to about 5% by weight, for example, about 0.1, about 0.2, about 0.3, about 0.4, about 0.5, about 0.6, about 0.7, about 0.8, about 0.9, or about 1% by weight to about 2, about 3, about 4, or about 5% by weight, based on the total weight of the composition.

[0200] In some embodiments, the binder comprises pectin. Pectin is a natural polymer related to carbohydrates and is an acidic heteropolysaccharide (a polysaccharide containing many monosaccharide units). Unlike carbohydrates, the C-6 position of pectin contains a carboxylic acid (or the corresponding methyl ester or carboxamide) group instead of a hydroxymethyl group. The major subunit is known as galacturonic acid, which can be copolymerized with L-rhamnose. Other sugars are characterized as side chain substituents. Pectin acts as a thickening and gelling agent. Pectin isolated from sources such as apple pomace, citrus peels, sugar beet waste from sugar manufacturing, sunflower heads discarded from seed harvest, mango waste, and other commercially available pectins can be used. In combination with certain sugars, under acidic conditions (e.g., pH of about 2.5 to about 5) or in the presence of gelling agents (calcium or other divalent alkaline earth elements), pectin can provide a gel or gum consistency to the compositions disclosed herein. In some embodiments, the binder comprises low methoxy pectin. Suitable low methoxy pectins include, for example, "GENU® Pectin Type LM-104 AS" available from CP Kelco, Atlanta, GA, USA. In some embodiments, the binder comprises low methoxy pectin in combination with a gelling agent. In some embodiments, the gelling agent comprises calcium ions, such as, but not limited to, calcium diphosphate. In some embodiments, the binder comprises high methoxy pectin in combination with an organic acid as described herein below. In some embodiments, the binder comprises high methoxy pectin in combination with citric acid.

[0201] If present, the pectin binder is typically present in an amount of up to about 3% by weight, based on the total weight of the composition, for example, about 0.1, about 0.2, about 0.3, about 0.4, about 0.5, about 0.6, about 0.7, about 0.8, about 0.9 or about 1 to about 1.1, about 1.2, about 1.3, about 1.4, about 1.5, about 1.6, about 1.7, about 1.8, about 1.9, about 2, about 2.1, about 2.2, about 2.3, about 2.4, about 2.5, about 2.6, about 2.7, about 2.8, about 2.9 or about 3% by weight.

[0202] organic acid In some embodiments, the composition includes an organic acid. As used herein, the term "organic acid" refers to an organic (i.e., carbon-based) compound characterized by acidic properties. Typically, organic acids are relatively weak acids (i.e., they do not completely dissociate in the presence of water), such as carboxylic acids (-CO2H) or sulfonic acids (-SO2OH). As used herein, reference to an organic acid refers to an organic acid that has been intentionally added. In this regard, an organic acid can be intentionally added as a specific mixture component, as opposed to one that is only essentially present as a component of another mixture component (e.g., a small amount of an organic acid that may be essentially present in a mixture component such as a tobacco material). In some embodiments, one or more organic acids are added neat (i.e., in their free acid, original solid or liquid form) or as a solution, e.g., to water. In some embodiments, one or more organic acids are added in the form of a salt, as described herein below.

[0203] Suitable organic acids typically have a range of lipophilicity (i.e., polarity that provides an appropriate balance of water and organic solubility). Lipophilicity is traditionally evaluated using logP, the partition coefficient of a molecule between the aqueous and lipophilic phases, usually water and octanol, respectively. Typically, the lipophilicity of an organic acid can be from about -2 to about 6.5. In some embodiments, the organic acid can be more soluble in water than in octanol (i.e., has a negative logP value, such as from about -2 to about -1). In some embodiments, the organic acid can be about equally soluble in water and octanol (i.e., has a logP value of about 0). In some embodiments, the organic acid can be more soluble in octanol than in water (i.e., has a positive logP value, such as from about 1 to about 6.5). In some embodiments, the organic acid has a logP value of about 1.5 to about 5.0, such as about 1.5, about 2.0, about 2.5, or about 3.0 to about 3.5, about 4.0, about 4.5, or about 5.0.

[0204] In some embodiments, the organic acid is a carboxylic acid or a sulfonic acid. The functional group of the carboxylic acid or sulfonic acid may be, for example, 1 to 12 carbon atoms (C1 to C 20 ) can be attached to any alkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl group. In some embodiments, the organic acid is an alkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl carboxylic or sulfonic acid.

[0205] As used herein, "alkyl" refers to any straight or branched chain hydrocarbon. The alkyl group is saturated (i.e., all sp 3 As used herein, the term "unsaturated" refers to a carbon-carbon, sp , or cyclic alkyl group that is unsaturated (i.e., has at least one site of unsaturation) at one or more locations within an alkyl group. 2It refers to the presence of a double bond. Unsaturated alkyl groups can be mono- or polyunsaturated. Representative straight chain alkyl groups include, but are not limited to, methyl, ethyl, n-propyl, n-butyl, n-pentyl, and n-hexyl. Branched chain alkyl groups include, but are not limited to, isopropyl, sec-butyl, isobutyl, tert-butyl, isopentyl, and 2-methylbutyl. Representative unsaturated alkyl groups include, but are not limited to, ethylene or vinyl, allyl, 1-butenyl, 2-butenyl, isobutylenyl, 1-pentenyl, 2-pentenyl, 3-methyl-1-butenyl, 2-methyl-2-butenyl, 2,3-dimethyl-2-butenyl, and the like. Alkyl groups can be unsubstituted or substituted.

[0206] "Cycloalkyl," as used herein, refers to a carbocyclic group, which may be monocyclic or bicyclic. Cycloalkyl groups include rings having 3 to 7 carbon atoms as a monocycle or rings having 7 to 12 carbon atoms as a bicycle. Examples of monocyclic cycloalkyl groups include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, and cyclooctyl. Cycloalkyl groups may be unsubstituted or substituted and may contain one or more points of unsaturation (e.g., cyclopentenyl or cyclohexenyl).

[0207] The term "aryl" as used herein refers to a carbocyclic aromatic group. Examples of aryl groups include, but are not limited to, phenyl and naphthyl. Aryl groups can be unsubstituted or substituted.

[0208] "Heteroaryl" and "heterocycloalkyl," as used herein, refer to an aromatic or non-aromatic ring system, respectively, in which one or more ring atoms are heteroatoms, such as nitrogen, oxygen, and sulfur. A heteroaryl or heterocycloalkyl group contains up to 20 carbon atoms and 1-3 heteroatoms selected from N, O, and S. A heteroaryl or heterocycloalkyl can be monocyclic having 3-7 ring members (e.g., 2-6 carbon atoms and 1-3 heteroatoms selected from N, O, and S) or bicyclic having 7-10 ring members (e.g., 4-9 carbon atoms and 1-3 heteroatoms selected from N, O, and S), such as a bicyclo[4,5], [5,5], [5,6], or [6,6] system. Examples of heteroaryl groups include, by way of example and not limitation, pyridyl, thiazolyl, tetrahydrothiophenyl, pyrimidinyl, furanyl, thienyl, pyrrolyl, pyrazolyl, imidazolyl, tetrazolyl, benzofuranyl, thianaphthalenyl, indolyl, indolenyl, quinolinyl, isoquinolinyl, benzimidazolyl, isoxazolyl, pyrazinyl, pyridazinyl, indolizinyl, isoindolyl, 3H-indolyl, 1H-indazolyl, purinyl, 4H-kynaphthalenyl, and the like. These include noridinyl, phthalazinyl, naphthyridinyl, quinoxalinyl, quinazolinyl, cinnolinyl, pteridinyl, 4aH-carbazolyl, carbazolyl, phenanthridinyl, acridinyl, pyrimidinyl, phenanthrolinyl, phenazinyl, phenothiazinyl, furazanyl, phenoxazinyl, isochromanyl, chromanyl, imidazolidinyl, imidazolinyl, pyrazolidinyl, pyrazolinyl, benzotriazolyl, benzisoxazolyl and isatinoyl. Examples of heterocycloalkyl include, by way of example and not limitation, dihydroypyridyl, tetrahydropyridyl (piperidyl), tetrahydrothiophenyl, piperidinyl, 4-piperidonyl, pyrrolidinyl, 2-pyrrolidonyl, tetrahydrofuranyl, tetrahydropyranyl, bis-tetrahydropyranyl, tetrahydroquinolinyl, tetrahydroisoquinolinyl, decahydroquinolinyl, octahydroisoquinolinyl, piperazinyl, quinuclidinyl, and morpholinyl.The heteroaryl and heterocycloalkyl groups can be unsubstituted or substituted.

[0209] "Substituted" as used herein and when applied to any of the above alkyl, aryl, cycloalkyl, heteroaryl, and heterocyclyl groups means that one or more halogen atoms are each independently replaced by a substituent. Exemplary substituents include, but are not limited to, -Cl, Br, F, alkyl, -OH, -OCH3, NH2, -NHCH3, -N(CH3)2, -CN, -NC(=O)CH3, -C(=O)-, -C(=O)NH2, and -C(=O)N(CH3)2. Whenever a group is described as "optionally substituted," the group can be substituted with one or more of the above substituents, selected independently for each circumstance. In some embodiments, the substituents can be one or more methyl groups or one or more hydroxyl groups.

[0210] In some embodiments, the organic acid is an alkyl carboxylic acid. Non-limiting examples of alkyl carboxylic acids include formic acid, acetic acid, propionic acid, octanoic acid, nonanoic acid, decanoic acid, undecanoic acid, dodecanoic acid, stearic acid, oleic acid, linoleic acid, linolenic acid, etc. In some embodiments, the organic acid is an alkyl sulfonic acid. Non-limiting examples of alkyl sulfonic acids include propane sulfonic acid and octane sulfonic acid.

[0211] In some embodiments, the alkyl carboxylic or sulfonic acids are substituted with one or more hydroxyl groups. Non-limiting examples include glycolic acid, 4-hydroxybutyric acid, and lactic acid.

[0212] In some embodiments, the organic acid may contain two or more carboxylic acid groups or two or more sulfonic acid groups (e.g., two, three or more carboxylic acid groups). Non-limiting examples include oxalic acid, fumaric acid, maleic acid, and glutaric acid. In organic acids containing multiple carboxylic acids (e.g., two to four carboxylic acid groups), one or more of the carboxylic acid groups can be esterified. Non-limiting examples include succinic acid monoethyl ester, monomethyl fumarate, monomethyl or dimethyl citrate, and the like.

[0213] In some embodiments, the organic acid may contain two or more carboxylic acid groups and one or more hydroxyl groups. Non-limiting examples of such acids include tartaric acid, citric acid, etc. In some embodiments, the organic acid is citric acid, sodium citrate, calcium citrate, or combinations thereof.

[0214] In some embodiments, the organic acid is an aryl carboxylic acid or aryl sulfonic acid. Non-limiting examples of aryl carboxylic and aryl sulfonic acids include benzoic acid, toluic acid, salicylic acid, benzenesulfonic acid, and p-toluenesulfonic acid.

[0215] Additional non-limiting examples of suitable organic acids include 2,2-dichloroacetic acid, 2-hydroxyethanesulfonic acid, 2-oxoglutaric acid, 4-acetamidobenzoic acid, 4-aminosalicylic acid, acetic acid, adipic acid, ascorbic acid (L), aspartic acid (L), camphoric acid (+), camphor-10-sulfonic acid (+), capric acid, caproic acid, caprylic acid, cinnamic acid, cyclamic acid, decanoic acid, dodecyl sulfuric acid, ethane-1,2-disulfonic acid, ethanes ... These include: sulfonic acid, formic acid, fumaric acid, galactaric acid, gentisic acid, glucoheptonic acid, gluconic acid, glucuronic acid, glutamic acid, glycerophosphoric acid, glycolic acid, hippuric acid, isobutyric acid, lactobionic acid, lauric acid, malonic acid, mandelic acid, methanesulfonic acid, naphthalene-1,5-disulfonic acid, naphthalene-2-sulfonic acid, oleic acid, palmitic acid, pamoic acid, pyroglutamic acid, sebacic acid, stearic acid and undecylenic acid.

[0216] In some embodiments, the one or more organic acids is a single organic acid. In some embodiments, the one or more organic acids is a combination of several acids, e.g., two, three or more organic acids.

[0217] The amount of organic acid present in the composition may vary. Generally, the mixture comprises about 0.1 to about 10 wt% of organic acid present as one or more organic acids based on the total weight of the composition. In some embodiments, the composition comprises about 0.1 wt%, about 0.2 wt%, about 0.3 wt%, about 0.4 wt%, about 0.5 wt%, about 0.6 wt%, about 0.7 wt%, about 0.8 wt%, about 0.9 wt%, about 1 wt%, about 2 wt%, about 3 wt%, about 4 wt%, about 5 wt%, about 6 wt%, about 7 wt%, about 8 wt%, about 9 wt%, or about 10 wt% of organic acid based on the total weight of the composition. In some embodiments, the composition comprises about 0.1 to about 0.5 wt. % of the organic acid, based on the total weight of the composition, for example, about 0.1, about 0.15, about 0.2, about 0.25, about 0.3, about 0.35, about 0.4, about 0.45, or about 0.5 wt. %. In some embodiments, the composition comprises about 0.25 to about 0.35 wt. % of the organic acid, based on the total weight of the composition, for example, about 0.25, about 0.26, about 0.27, about 0.28, about 0.29, or about 0.3 to about 0.31, about 0.32, about 0.33, about 0.34, or about 0.35 wt. %. When a salt of the organic acid is added (e.g., sodium citrate), the weight percentage is calculated based on the weight of the free acid, not including any counterion that may be present.

[0218] The organic acid (e.g., citric acid) can be added neat (i.e., as a solid) or in solution, e.g., in water. In some embodiments, the organic acid is added as a 50% aqueous solution.

[0219] Buffering Agent In certain embodiments, the compositions of the present disclosure may include a pH adjusting agent or a buffering agent. Examples of pH adjusting agents and buffering agents that can be used include, but are not limited to, metal hydroxides (e.g., alkali metal hydroxides, such as sodium hydroxide and potassium hydroxide) and other alkali metal buffers, such as metal carbonates (e.g., potassium carbonate or sodium carbonate) or metal bicarbonates, such as sodium bicarbonate. Non-limiting examples of suitable buffering agents include alkali metal acetates, glycinates, phosphates, glycerophosphates, citrates, carbonates, bicarbonates, borates, or combinations thereof. In some embodiments, the buffering agent is sodium bicarbonate.

[0220] If present, the buffering agent is typically present in an amount of less than about 5% by weight based on the weight of the composition, for example, from about 0.1% to about 5% by weight, such as from about 0.1% to about 1% by weight or from about 0.1% to about 0.5% by weight based on the total weight of the composition.

[0221] Coloring agent Coloring agents can be utilized in an amount sufficient to provide the composition with the desired physical attributes. Examples of coloring agents include various dyes and pigments, such as caramel color and titanium dioxide. Natural coloring agents such as curcumin, beet juice extract, spirulina, and the like; also, various synthetic pigments can be used. The amount of coloring agent utilized in the composition can vary, but when present, is typically up to about 3% by weight, for example, about 0.1%, about 0.5%, or about 1% to about 3% by weight, based on the total weight of the composition.

[0222] Wetting Agent In certain embodiments, one or more humectants can be utilized in the composition. Examples of humectants include, but are not limited to, glycerin, propylene glycol, and the like. If included, the humectant is typically provided in an amount sufficient to impart desired humectant attributes to the composition. Additionally, in some instances, the humectant can impart desired flow properties to the composition for depositing into a mold. If present, the humectant typically comprises about 5% or less by weight of the composition (e.g., about 0.1 to about 5% by weight), e.g., about 0.1% to about 1% by weight or about 1% to about 5% by weight, based on the total weight of the composition.

[0223] Oral Care Additives In some embodiments, the composition comprises an oral care ingredient (or a mixture of such ingredients). The oral care ingredient provides the ability to inhibit dental caries or loss, inhibit periodontal disease, relieve oral pain, whiten or inhibit tooth staining, induce saliva stimulation, inhibit breath malodor, freshen breath, etc. For example, effective amounts of ingredients such as thyme oil, eucalyptus oil, and zinc (such as ingredients of the formulations marketed as ZYTEX® by Discus Dental) can be incorporated into the composition. Other examples of ingredients that can be incorporated in the present compositions in desired effective amounts include those incorporated in the types of oral care compositions described in Takahashi et al., Oral Microbiology and Immunology, 19(1), pp. 61-64 (2004); Thistle, U.S. Patent No. 6,083,527; and Jakubowski, U.S. Patent Application Publication No. 2006 / 0210488 and Cummins et al., U.S. Patent Application Publication No. 2006 / 02228308. Other exemplary ingredients of tobacco-containing formulations include those contained in formulations sold as MALTISORB® by Roquette and DENTIZYME® by NatraRx. When present, a representative amount of oral care additive is at least about 1%, often at least about 3%, and frequently at least about 5% of the total dry weight of the composition. The amount of oral care additive within the composition typically does not exceed about 30%, often does not exceed about 25%, and frequently does not exceed about 20% by total dry weight of the composition.

[0224] Processing Aids If necessary for downstream processing of the composition, such as granulation, mixing or molding, flow aids can also be added to the composition to improve the flowability of the composition. In some embodiments, the composition (e.g., in the form of melts and chews) can be surface treated with a flow agent, such as oil, silicone, etc. Exemplary flow aids include microcrystalline cellulose, silica, polyethylene glycol, stearic acid, calcium stearate, magnesium stearate, zinc stearate, sodium stearyl fumarate, carnauba wax, and combinations thereof. In some embodiments, the flow aid is sodium stearyl fumarate.

[0225] When present, a representative amount of flow aid can comprise at least about 0.5 percent or at least about 1 percent of the total dry weight of the composition. Preferably, the amount of flow aid in the composition does not exceed about 5 percent, and frequently does not exceed about 3 percent, of the total dry weight of the composition.

[0226] emulsifier In certain embodiments, an emulsifier can be added. In some embodiments, the emulsifier is lecithin. For example, lecithin (e.g., soybean lecithin or sunflower lecithin) can be added to the composition to provide a smoother texture characteristic to the composition, for example to improve the flowability and mixing of the lipid containing remaining components of the composition. The emulsifier (e.g., lecithin) can be used in an amount of about 0.01 to about 5% by dry weight of the composition, for example, about 0.1 to about 2.5% or about 0.1 to about 1.0% based on the total weight of the composition.

[0227] Other Additives Other additives can be included in the disclosed compositions. For example, the compositions can be processed, blended, formulated, combined and / or mixed with other materials or ingredients. The additives can be artificial or can be obtained or derived from herbal or biological sources. Examples of further types of additives include thickening or gelling agents (e.g., fish gelatin), emulsifiers, preservatives (e.g., potassium sorbate, etc.), disintegration aids, zinc or magnesium salts selected to be relatively water-soluble in compositions with higher water solubility (e.g., magnesium gluconate or zinc gluconate) or relatively poorly water-soluble in compositions with low water solubility (e.g., magnesium oxide or zinc oxide), or combinations thereof. See, for example, U.S. Patent No. 9,237,769 to Mua et al., U.S. Patent No. 7,861,728 to Holton, Jr. et al., U.S. Patent Application Publication No. 2010 / 0291245 to Gao et al., and U.S. Patent Application Publication No. 2007 / 0062549 to Holton, Jr. et al. for representative components, combinations of components, relative amounts of components, and techniques and methods for utilizing the components, each of which is incorporated herein by reference. Typical inclusion ranges for such additional additives can vary depending on the nature and function of the additive and the intended effect of the final composition, with exemplary ranges being up to about 10% by weight (e.g., about 0.1 to about 5% by weight) based on the total weight of the composition.

[0228] In some embodiments, the composition comprises a magnesium salt. A non-limiting example of a suitable magnesium salt is magnesium gluconate. In some embodiments, the composition comprises magnesium in an amount of about 0.1% to about 2% by weight or about 0.2 to about 1% by weight based on elemental magnesium.

[0229] The aforementioned additives can be utilized together (e.g., an additive formulation) or separately (e.g., individual additive components can be added at different stages involved in the preparation of the final composition). Additionally, the aforementioned types of additives can be encapsulated as provided in the final product or composition. Exemplary encapsulated additives are described, for example, in WO 2010 / 132444 to Atchley, which has been previously incorporated by reference herein.

[0230] Constructed for use in the oral cavity Provided herein is a composition that is configured for use in the oral cavity. The term "configured for use in the oral cavity" as used herein means that the composition is provided in such a form that during use, the saliva in the user's oral cavity sends one or more of the components of the composition (e.g., flavoring agent and / or active ingredient) to the user's oral cavity. In certain embodiments, the composition is adapted to deliver ingredients to the user through the mucous membrane of the user's oral cavity, the user's digestive system, or both, and in some cases, the ingredients are active ingredients (e.g., but not limited to, stimulants, vitamins, amino acids, botanicals, or combinations thereof) that can be absorbed through the mucous membrane in the oral cavity or absorbed through the digestive tract when the product is used.

[0231] Compositions configured for use in the oral cavity described herein can take a variety of forms, including gels, pastilles, gums, chews, melts, tablets, lozenges, powders, and pouches. Gels can be soft or hard. Certain compositions configured for use in the oral cavity are in the form of pastilles. As used herein, the term "pastel" refers to dissolvable oral compositions made by solidifying a liquid or gel compositions where the final composition is a somewhat hardened solid gel. Gels can vary widely in stiffness. Certain compositions of the present disclosure are in solid form. Certain compositions can exhibit, for example, one or more of the following characteristics: crispy, granular, chewy, syrupy, pasty, fluffy, smooth, and / or creamy. In certain embodiments, the desired texture characteristic may be selected from the group consisting of adhesiveness, cohesiveness, density, dryness, fragility, graininess, stickiness, hardness, weightiness, moisture absorption, moisture release, mouthcoating, roughness, slipperiness, smoothness, stickiness, wetness, and combinations thereof.

[0232] The compositions disclosed herein can be formed into a variety of shapes, including pills, tablets, spheres, strips, films, sheets, coins, cubes, beads, ovals, obloids, cylinders, beans, sticks, or rods. The cross-sectional shape of the composition can vary, with exemplary cross-sectional shapes including circles, squares, ovals, rectangles, etc. Such shapes can be formed in a variety of ways using equipment such as moving belts, nips, extruders, granulators, compression molding devices, etc.

[0233] The compositions of the present disclosure are dissolvable. As used herein, the terms "dissolve", "dissolving" and "dissolvable" refer to a composition having water-soluble components that interact with moisture in the oral cavity and go into solution, resulting in gentle consumption of the composition. According to one aspect, a dissolvable composition is capable of remaining in the oral cavity of a user for a period of time until it completely dissolves. The dissolution rate can vary over a wide range, from about 1 minute or less to about 60 minutes. For example, a fast-release composition typically dissolves and / or releases the desired components (e.g., active ingredients, flavors, etc.) in about 2 minutes or less, often about 1 minute or less (e.g., about 50 seconds or less, about 40 seconds or less, about 30 seconds or less, or about 20 seconds or less). Dissolution can occur by any means, such as melting, mechanical disruption (e.g., chewing), enzymatic or other chemical degradation, or by disruption of interactions between the components of the composition. In other embodiments, the product does not dissolve during the product's residence in the oral cavity of the user.

[0234] In some embodiments, the composition may be chewable, meaning that the composition has a slight elasticity or "bounce" when chewed, with a desired degree of flexibility. The chewable form of the composition may be in the form of a non-dissolving gum that can be completely dissolved or where only certain ingredients (e.g., active ingredients, flavors, sweeteners) dissolve, leaving a non-dissolving matrix. Chewable embodiments generally include a binder such as a natural gum or pectin. In some embodiments, the chewable form of the composition includes pectin and an organic acid, together with one or more sugar alcohols in an amount of at least 50% by weight, based on the total weight of the composition. Generally, the pectin is present in an amount of about 1 to about 3% by weight, based on the total weight of the composition.

[0235] In some embodiments, the composition may be a meltable agent, as discussed in, for example, U.S. Patent Application Publication No. 2012 / 0037175, Cantrell et al., which is incorporated herein by reference in its entirety. As used herein, "melt", "melting" and "meltable agent" refer to the ability of a composition to change from a solid state to a liquid state. That is, melting typically occurs when a substance (e.g., a composition disclosed herein) changes from a solid to a liquid upon application of heat. The application of heat to a composition disclosed herein is brought about by the internal temperature of the user's oral cavity. Thus, the term "meltable" refers to a composition that is capable of liquefying in the oral cavity of a user as the composition undergoes a phase change from solid to liquid, and is intended to distinguish compositions that simply disintegrate in the oral cavity through loss of tackiness from compositions that simply dissolve in the oral cavity as the water-soluble components of the composition interact with moisture. In general, meltable compositions include lipids, as described herein above. In some embodiments, the composition in meltable form comprises lipid in an amount of about 35 to about 50% by weight based on the total weight of the composition and sugar alcohol in an amount of about 35 to about 55% by weight based on the total weight of the composition. In some embodiments, the sugar alcohol is isomalt, erythritol, sorbitol, arabitol, ribitol, maltitol, dulcitol, iditol, mannitol, xylitol, lactitol or a combination thereof. In some embodiments, the sugar alcohol is isomalt.

[0236] In certain embodiments, the composition is in the form of compressed or molded pellets. Exemplary weights of the pellets range from about 250 mg to about 1500 mg, such as from about 250 mg to about 700 mg or from about 700 mg to about 1500 mg. The pellets can have any of a variety of shapes, including traditional pill or tablet shapes. Generally, the composition in the form of a tablet comprises a glucose-polysaccharide blend as well as a sugar alcohol. In some embodiments, the glucose-polysaccharide blend is present in an amount of about 35 to about 50% by weight based on the total weight of the composition; the sugar alcohol is present in an amount of about 30 to about 45% by weight based on the total weight of the composition. In some embodiments, the sugar alcohol is isomalt, erythritol, sorbitol, arabitol, ribitol, maltitol, dulcitol, iditol, mannitol, xylitol, lactitol, or a combination thereof. In some embodiments, the sugar alcohol is isomalt.

[0237] Preparation of the Composition The manner in which the various components of the composition (e.g., fillers, active ingredients, etc.) are combined can vary. Thus, the entire composition, including, for example, powdered composition components, can be relatively homogenous (e.g., uniform) in nature. The above-mentioned components, which can be in the form of liquid or dry solids, can be mixed in a pretreatment step before mixing with any remaining components of the composition, or simply mixed together with all other liquid or dry ingredients. The compositions of the present disclosure are prepared by dry blending dry ingredients, such as, for example, fillers, sweeteners, salts, etc. In certain embodiments, water can be added to the dry blend at this stage. In addition, it is optional to add active ingredients and / or flavorings, for example, by spraying them into the dry blend and then mixing.

[0238] The various components of the composition can be contacted, combined or mixed together using any mixing technique or equipment known in the art. Any mixing method that brings the composition components into intimate contact can be used, for example, a mixing device that features an impeller or other structure that allows stirring. Examples of mixing equipment include casting drums, conditioning cylinders or drums, liquid spraying devices, conical type blenders, ribbon blenders, mixers available as FKM130, FKM600, FKM1200, FKM2000 and FKM3000 manufactured by Littleford Day, Inc., Plough Share type mixer cylinders, Hobart mixers, and the like. Also, see, for example, the types of methods described in U.S. Patent No. 4,148,325 to Solomon et al.; U.S. Patent No. 6,510,855 to Korte et al.; and U.S. Patent No. 6,834,654 to Williams, each of which is incorporated herein by reference. In some embodiments, the components that form the composition are prepared so that the mixture can be used in the starch forming process to form the composition.The manner and method of formulating the composition are clear to those skilled in the art.See also, for example, the types of methods described in U.S. Patent No. 4,148,325 to Solomon et al.; U.S. Patent No. 6,510,855 to Korte et al.; and U.S. Patent No. 6,834,654 to Williams, U.S. Patent No. 4,725,440 to Ridgway et al. and U.S. Patent No. 6,077,524 to Bolder et al., each of which is incorporated herein by reference.

[0239] In some embodiments, the composition is in the form of compressed pellets or tablets. In one embodiment, the process of making pellets or tablets includes first mixing the bulk filler (e.g., EMDEX®) and the active ingredient. The remaining composition components (e.g., sugar alcohol and any other desired components, such as binders, colorants, sweeteners, flavors, etc.) are then added. Optionally, the colorant can be added to one of the composition components in a separate step before mixing with the remaining components of the composition. The mixing of the composition can be performed using any mixing device. The final composition is then compressed into pellet or tablet form using conventional tableting techniques and is optionally coated. The compressed composition pellets can be produced by compressing the composition with any relevant formulation components in the form of pellets, and optionally coating each pellet with an overcoat material. Exemplary compression molding devices, such as compression molding presses, are available as Colton 2216 and Colton 2247 from Vector Corporation and 1200i, 2200i, 3200, 2090, 3090 and 4090 from Fette Compacting. Devices for applying an outer coating layer to the compression molded pelletized composition are available as CompuLab 24, CompuLab 36, Accela-Cota 48 and Accela-Cota 60 from Thomas Engineering. If present, the coating typically comprises a film-forming polymer, such as a cellulosic polymer, an optional plasticizer and optional flavors, colors, salts, sweeteners or other additives of the type described herein. The coating composition is usually aqueous in nature and can be applied using any pellet or tablet coating technique known in the art, such as pan coating. Examples of film-forming polymers include cellulosic polymers such as methylcellulose, hydroxypropylcellulose (HPC), hydroxypropylmethylcellulose (HPMC), hydroxyethylcellulose and carboxymethylcellulose.Examples of plasticizers include aqueous solutions or emulsions of glyceryl monostearate and triethyl citrate. Additional latent coatings include food grade shellac, waxes such as carnuaba wax, and combinations thereof.

[0240] In some embodiments, the composition is in a chewable form. For the preparation of the chewable form of the composition, generally, the pectin binder is pre-blended with a portion of the isomalt. Water is added and the mixture is heated to boiling with stirring. Maltitol syrup and any remaining isomalt are added to the boiling mixture along with active ingredients (e.g., caffeine, taurine and vitamin C) followed by trisodium citrate. The mixture is cooked to 78 Brix. The heat is removed and sweeteners (e.g., sucralose and acesulfame K) and flavors are added along with colorants and citric acid solution (or dicalcium phosphate) and the mixture is thoroughly combined. The composition is precipitated into a starch mold for storage at ambient temperature.

[0241] In some embodiments, the composition is in a meltable form. For the preparation of meltable compositions, lipids are typically heated to slightly above their melting temperature to liquefy the lipids. Optionally, active ingredients, flavorings and / or lecithin can be added to the liquefied lipids at this stage. Thus, all or part of the liquefied lipids can be blended with the dry blend and mixed until the composition reaches a desired level of uniformity or until the desired textural characteristics are achieved. The mixture is milled (e.g., in a dry roll) to a particle size of less than about 20 microns. The milled isomalt-palm oil is combined with any remaining lipids, and the dry ingredients and flavors are mixed therein. The base is generally warmed to a liquid consistency. The composition can be divided into separate portions, for example, by pouring the composition into a sheet-like structure, cooling, and then cutting the structure into individual portions, or by depositing the composition into a mold and allowing it to cool.

[0242] Many modifications and other embodiments of the invention will come to mind to one skilled in the art to which this invention pertains having the benefit of the teachings presented in the foregoing description. It is to be understood, therefore, that the invention is not limited to the specific embodiments disclosed, but that modifications and other embodiments are intended to be included within the scope of the appended claims. Although specific terms are employed herein, they are used in a generic and descriptive sense only and not for purposes of limitation. EXAMPLES

[0243] Aspects of the present invention will be more fully described by the following examples, which are presented to illustrate certain specific aspects of the invention and should not be construed as limiting thereof.

[0244] Example 1. Tablets containing theanine, GABA and lemon balm A composition in the form of a tablet according to an embodiment of the present disclosure was prepared from a composition containing a mixture of fillers, a mixture of theanine, GABA (gamma aminobutyric acid) and lemon balm as active ingredients, and additional ingredients (salt, sweetener, processing aids) disclosed herein. The fillers, sweeteners, salt, active ingredients and processing aids were combined and thoroughly mixed. The mixture was compressed and tableted using a Fette 1200i tablet press. The tablets were coated with wax and shellac. The ingredients of the composition and their concentrations in the composition by weight % are shown in Table 1. The tablet weight was 1000 mg each.

[0245] [Table 1]

[0246] Example 2. Tablets containing caffeine, taurine and vitamin C A composition in the form of a tablet according to an embodiment of the present disclosure was prepared from a composition containing a mixture of fillers, a mixture of caffeine, taurine and vitamin C as active ingredients, and additional ingredients (salt, sweeteners, buffers, processing aids) as disclosed herein, using the method of Example 1. The ingredients of the composition and their concentrations in the composition in % by weight are shown in Table 2. The tablet weight was 1000 mg each.

[0247] [Table 2]

[0248] Example 3. Tablets containing caffeine, theanine, sunflower lecithin and carrot A composition in the form of a tablet according to an embodiment of the present disclosure was prepared from a composition containing a mixture of fillers, a mixture of caffeine, theanine, sunflower lecithin and carrot as active ingredients, and additional ingredients (salt, sweeteners, buffers, processing aids) as disclosed herein, using the method of Example 1. The ingredients of the composition and their concentrations in the composition in % by weight are shown in Table 3. The tablet weight was 1000 mg each.

[0249] [Table 3]

[0250] Example 4. Chewable agent containing caffeine, taurine and vitamin C A chewable form of composition according to an embodiment of the present disclosure was prepared from a composition containing a mixture of fillers, a mixture of caffeine, taurine and vitamin C as active ingredients, and additional ingredients disclosed herein (salt, sweeteners, flavorings, water, binders, citric acid, gelling agents). The ingredients of the composition and their concentrations in the composition by weight % are shown in Table 4.

[0251] The pectin binder was pre-blended with a portion of the isomalt. Water was added and the mixture was heated to boiling with stirring. Maltitol syrup and any remaining isomalt were added to the boiling mixture along with the active ingredients (e.g., caffeine, taurine and vitamin C) followed by trisodium citrate. The mixture was heated to 78 Brix. The heat was removed and sweeteners (e.g., sucralose and acesulfame K), colors and flavors were added along with citric acid and dicalcium phosphate, the mixture was thoroughly combined and the composition was deposited into a starch mold for storage at ambient temperature. The chews weighed 2600 mg each.

[0252] [Table 4]

[0253] Example 5. Chewable agent containing theanine, GABA and lemon balm Chewable forms of compositions according to embodiments of the present disclosure were prepared from compositions containing a mixture of fillers, a mixture of theanine, GABA and lemon balm as active ingredients, and additional ingredients disclosed herein (salt, sweeteners, flavorings, water, binders, citric acid, gelling agents) using the method of Example 4. The ingredients of the compositions and their concentrations in the compositions by weight % are shown in Table 5. The chew weights were 2600 mg each.

[0254] [Table 5]

[0255] Example 6. Chewable agent containing caffeine, theanine and carrot Chewable forms of compositions according to embodiments of the present disclosure were prepared from compositions containing a mixture of fillers, a mixture of caffeine, theanine and carrot as active ingredients, and additional ingredients disclosed herein (salt, sweeteners, flavorings, water, binders, citric acid, gelling agents) using the method of Example 4. The ingredients of the compositions and their concentrations in the compositions by weight % are shown in Table 6. The chew weights were 2600 mg each.

[0256] [Table 6]

[0257] Example 7. Meltable agent containing theanine, GABA and lemon balm A meltable form of composition according to an embodiment of the present disclosure was prepared from a composition containing a filler, lipid, theanine as an active ingredient, a mixture of GABA and lemon balm, and additional ingredients (salt, sweetener, flavoring agent) as disclosed herein. The ingredients of the composition and their concentrations in the composition by weight % are shown in Table 7.

[0258] A portion of the palm oil was melted and mixed with the isomalt in a mixer. The mixture was transferred to a dry roll mill and ground to a particle size of less than 20 microns. The ground isomalt-palm oil was combined with the remaining portion of the palm oil in a mixer. The base was warmed to a liquid consistency. Sunflower oil, dry ingredients and flavors were mixed. The isomalt-palm oil-ingredients mixture was transferred to a heated depositing funnel. An appropriate weight of sample was deposited into the mold. If necessary, the mold was placed on a vibrator to ensure filling. The product was cooled and solidified, then removed from the mold. The melt weight was 1300 mg each.

[0259] [Table 7]

[0260] Example 8. Meltable agent containing theanine, caffeine and carrot Meltable forms of compositions according to embodiments of the present disclosure were prepared from compositions containing fillers, lipids, theanine as active ingredients, a mixture of caffeine and carrot, and additional ingredients disclosed herein (salt, sweeteners, flavorings, buffers) using the method of Example 7. The components of the compositions and their concentrations in the compositions by weight % are shown in Table 8. The melt weights were 1300 mg each.

[0261] [Table 8]

[0262] Example 9. Meltable agent containing taurine, caffeine and vitamin C Compositions according to embodiments of the present disclosure in meltable form were prepared using the method of Example 7 from compositions containing fillers, lipids, a mixture of taurine, caffeine and vitamin C as active ingredients, and additional ingredients disclosed herein (salt, sweeteners, flavorings, buffers, emulsifiers). The components of the compositions and their concentrations in the compositions by weight % are shown in Table 9. The melt weights were 1300 mg each.

[0263] [Table 9]

Claims

1. 1. A composition in chewable form adapted for use in the oral cavity, comprising: at least one active ingredient selected from the group consisting of caffeine, taurine, GABA, theanine, tryptophan, vitamin B6, vitamin B12, vitamin C, lemon balm extract, carrot, citicoline, sunflower lecithin, and combinations thereof; one or more sugar alcohols in an amount of at least 50% by weight, based on the total weight of the composition; Pectin; and Organic acid, gelling agent, or both wherein the composition is a homogenous mixture.

2. 2. The composition of claim 1, wherein the one or more sugar alcohols is a combination of isomalt and maltitol.

3. Isomalt in an amount of about 10 to about 25% by weight, based on the total weight of the composition; Maltitol in an amount of about 50 to about 75% by weight, based on the total weight of the composition; and Pectin in an amount of about 1 to about 3% by weight, based on the total weight of the composition. The composition of claim 1 or 2, comprising:

4. The composition according to any one of claims 1 to 3, wherein the organic acid is citric acid.

5. The composition of any one of claims 1 to 4, wherein the at least one active ingredient comprises a combination of caffeine, theanine, and optionally ginseng.

6. caffeine is present in an amount of about 1 to about 4% by weight, based on the total weight of the composition; theanine is present in an amount of about 1 to about 4% by weight, based on the total weight of the composition; Carrot is present in an amount of about 0.1 to about 0.6% by weight, based on the total weight of the composition. The composition of claim 5.

7. 7. The composition of claim 6, further comprising citicoline or sunflower lecithin.

8. 5. The composition of any one of claims 1 to 4, wherein the at least one active ingredient comprises a combination of theanine, gamma aminobutyric acid (GABA), and optionally lemon balm extract.

9. theanine is present in an amount of about 1 to about 3% by weight, based on the total weight of the composition; GABA is present in an amount of about 1.5 to about 4% by weight, based on the total weight of the composition; The lemon balm extract is present in an amount of about 0.25 to about 2% by weight, based on the total weight of the composition. The composition of claim 8.

10. The composition according to any one of claims 1 to 4, wherein at least one active ingredient is Theanine; Theanine and tryptophan; or Theanine and Vitamin B6, Vitamin B12, or both A composition comprising:

11. 11. The composition of claim 10, comprising theanine and one or both of vitamin B6 and vitamin B12.

12. The composition of any one of claims 1 to 4, wherein the at least one active ingredient comprises a combination of caffeine, taurine and vitamin C.

13. caffeine is present in an amount of about 1 to about 4% by weight, based on the total weight of the composition; taurine is present in an amount of about 1 to about 4% by weight, based on the total weight of the composition; Vitamin C is present in an amount of about 1 to about 3% by weight, based on the total weight of the composition. The composition of claim 12.

14. 14. The composition of claim 13 further comprising trisodium citrate.

15. 15. The composition of any one of claims 1 to 14, further comprising at least one additional ingredient selected from water, sweeteners, salts, flavors, buffers, emulsifiers, colorants, processing aids, and combinations thereof.

16. The composition according to any one of claims 1 to 15, which is nicotine-free.

17. The composition according to any one of claims 1 to 16, which is tobacco-free.

18. 1. A composition in the form of a tablet adapted for use in the oral cavity, comprising: at least one active ingredient selected from the group consisting of caffeine, taurine, GABA, theanine, tryptophan, vitamin B6, vitamin B12, vitamin C, lemon balm extract, carrot, citicoline, sunflower lecithin, and combinations thereof; Glucose-polysaccharide blends; and Sugar alcohols wherein the tablet form comprises the composition as a homogenous mixture.

19. the glucose-polysaccharide blend is present in an amount of about 35 to about 55% by weight, based on the total weight of the composition; The sugar alcohol is present in an amount of about 30 to about 45% by weight, based on the total weight of the composition.

20. The composition of claim 18.

20. 20. The composition of claim 18 or 19, wherein the sugar alcohol is isomalt, erythritol, sorbitol, arabitol, ribitol, maltitol, dulcitol, iditol, mannitol, xylitol, lactitol or a combination thereof.

21. The composition according to any one of claims 18 to 20, wherein the sugar alcohol is isomalt.

22. 22. The composition of any one of claims 18 to 21, wherein the at least one active ingredient comprises a combination of caffeine, theanine, and optionally ginseng.

23. caffeine is present in an amount of about 3 to about 5% by weight, based on the total weight of the composition; theanine is present in an amount of about 3 to about 5% by weight, based on the total weight of the composition; Carrot is present in an amount of about 0.4 to about 0.6% by weight, based on the total weight of the composition.

23. The composition of claim 22.

24. 24. The composition of claim 23, further comprising citicoline or sunflower lecithin.

25. 22. The composition of any one of claims 18 to 21, wherein the at least one active ingredient comprises a combination of theanine, gamma aminobutyric acid (GABA), and optionally lemon balm extract.

26. theanine is present in an amount of about 3 to about 5% by weight, based on the total weight of the composition; GABA is present in an amount of about 4 to about 6% by weight, based on the total weight of the composition; The lemon balm extract is present in an amount of about 3 to about 4% by weight, based on the total weight of the composition.

26. The composition of claim 25.

27. The composition of any one of claims 18 to 21, wherein the at least one active ingredient comprises a combination of caffeine, taurine and vitamin C.

28. caffeine is present in an amount of about 3 to about 5% by weight, based on the total weight of the composition; taurine is present in an amount of about 4 to about 6% by weight, based on the total weight of the composition; Vitamin C is present in an amount of about 4 to about 6% by weight, based on the total weight of the composition; 28. The composition of claim 27.

29. 30. The composition of claim 28, further comprising trisodium citrate.

30. 30. The composition of any one of claims 18 to 29, further comprising at least one additional ingredient selected from sweeteners, salts, flavors, buffers, emulsifiers, colorants, processing aids, and combinations thereof.

31. The composition according to any one of claims 18 to 30, which is nicotine-free.

32. The composition of any one of claims 18 to 31, which is tobacco-free.

33. 1. A composition in a dissolvable form adapted for use in the oral cavity, comprising: at least one active ingredient selected from the group consisting of caffeine, taurine, GABA, theanine, tryptophan, vitamin B6, vitamin B12, vitamin C, lemon balm extract, carrot, citicoline, sunflower lecithin, and combinations thereof; Sugar alcohols; and Lipids wherein the meltable form comprises the composition as a homogenous mixture.

34. The sugar alcohol is present in an amount of about 35 to about 55% by weight, based on the total weight of the composition; The lipid is present in an amount of about 35 to about 55% by weight, based on the total weight of the composition.

34. The composition of claim 33.

35. 35. The composition of claim 33 or 34, wherein the lipid has a melting point of about 29°C or higher.

36. 36. The composition of any one of claims 33 to 35, wherein the lipid has a melting point of from about 36°C to about 45°C.

37. 37. The composition of any one of claims 33 to 36, wherein the lipid is an oil selected from the group consisting of palm oil, palm kernel oil, soybean oil, sunflower oil, cottonseed oil, coconut oil and combinations thereof, and the oil may be hydrogenated, partially hydrogenated or non-hydrogenated.

38. 38. The composition of any one of claims 33 to 37, wherein the sugar alcohol is isomalt, erythritol, sorbitol, arabitol, ribitol, maltitol, dulcitol, iditol, mannitol, xylitol, lactitol or a combination thereof.

39. 39. The composition of any one of claims 33 to 38, wherein the sugar alcohol is isomalt.

40. 40. The composition of any one of claims 33 to 39, wherein the at least one active ingredient comprises a combination of caffeine, theanine, and optionally ginseng.

41. caffeine is present in an amount of about 2 to about 6% by weight, based on the total weight of the composition; theanine is present in an amount of about 2 to about 4% by weight, based on the total weight of the composition; Carrot is present in an amount of about 0.3 to about 0.5% by weight, based on the total weight of the composition.

41. The composition of claim 40.

42. 42. The composition of claim 41, further comprising citicoline or sunflower lecithin.

43. 41. The composition of claim 40, wherein at least a portion of the caffeine is present in encapsulated form.

44. 40. The composition of any one of claims 33 to 39, wherein the at least one active ingredient comprises a combination of theanine, gamma aminobutyric acid (GABA), and optionally lemon balm extract.

45. theanine is present in an amount of about 2 to about 4% by weight, based on the total weight of the composition; GABA is present in an amount of about 3.5 to about 4.5% by weight, based on the total weight of the composition; The lemon balm extract is present in an amount of about 1.5 to about 2.5% by weight, based on the total weight of the composition.

45. The composition of claim 44.

46. 38. The composition of any one of claims 31 to 37, wherein the at least one active ingredient comprises a combination of caffeine, taurine and vitamin C.

47. caffeine is present in an amount of about 2 to about 6% by weight, based on the total weight of the composition; taurine is present in an amount of about 3.5 to about 4.5% by weight, based on the total weight of the composition; Vitamin C is present in an amount of about 3.5 to about 4.5% by weight, based on the total weight of the composition; 47. The composition of claim 46.

48. 47. The composition of claim 46, wherein at least a portion of the caffeine is present in encapsulated form.

49. 47. The composition of claim 46, further comprising trisodium citrate.

50. 50. The composition of any one of claims 33-49, further comprising at least one additional ingredient selected from sweeteners, salts, flavorings, buffers, emulsifiers, colorants, processing aids, and combinations thereof.

51. The composition of any one of claims 33 to 50, which is nicotine-free.

52. 52. The composition of any one of claims 33 to 51, which is tobacco-free.

53. At least one active ingredient is a) caffeine in an amount of about 1.5 to about 5% by weight, based on the total weight of the composition; Taurine in an amount of about 1.5 to about 6% by weight, based on the total weight of the composition; Vitamin C in an amount of about 2 to about 6% by weight, based on the total weight of the composition. ; and Sodium citrate in an amount of about 1 to about 3% by weight, based on the total weight of the composition; or a combination of b) theanine in an amount of about 1 to about 5% by weight, based on the total weight of the composition; GABA in an amount of about 1.5 to about 6% by weight, based on the total weight of the composition; and Lemon balm extract in an amount of about 1 to about 4% by weight, based on the total weight of the composition; or a combination of c) caffeine in an amount of about 1.5 to about 6% by weight, based on the total weight of the composition; theanine in an amount of about 1.5 to about 5% by weight, based on the total weight of the composition; Carrot in an amount of about 0.2 to about 0.6% by weight, based on the total weight of the composition; and, optionally, Citicoline or sunflower lecithin in an amount of about 0.3 to about 1.5% by weight, based on the total weight of the composition.

34. The composition of any one of claims 1, 18 or 33, which is a combination of:

54. 54. The composition of any one of claims 1 to 53, further comprising magnesium.

Citation Information

Patent Citations

  • Tobacco-tablet

    US1376586A

  • Smokeless tobacco product

    US20040020503A1

  • Flavored smokeless tobacco and methods of making

    US20050115580A1

  • Tobacco compositions

    US20060191548A1

  • Smokeless tobacco composition

    US20070062549A1

Cited By

  • Oral Products and Methods of Manufacturing

    JP2024509922A